• Home
  • About Us
  • List of Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Archives for Annalyn Frame

Community-Based Lifestyle Intervention Yields Weight Loss, Reduced Glucose Results Similar to Those in DPP

Posted on June 29, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

ORLANDO, FL–(Marketwire – June 29, 2010) –  A community-based lifestyle intervention program, modeled after one used in a landmark government funded diabetes-prevention study, can help participants in a group setting achieve weight loss and blood glucose reductions comparable to those achieved with individual counseling from health professionals, according to data presented by researchers at the American Diabetes Association’s 70th Scientific Sessions®.

In the Healthy Living Partnerships to Prevent Diabetes (HELP PD) study, participants were divided into two groups: a lifestyle weight loss group, which received six months of weekly behavioral weight loss sessions in a group setting, followed by monthly follow-up meetings, at which they were encouraged to change eating behaviors and exercise up to 180 minutes per week; and a usual care group, which received two visits with a dietitian and a quarterly newsletter with tips for lifestyle changes. The group weight loss sessions were delivered by lay community health workers trained and supervised by dietitians at the Wake Forest Diabetes Care Center in Winston-Salem, North Carolina.

The study found that those in the lifestyle intervention group achieved and maintained significantly greater weight loss (an average of 7.3 percent of body weight) than those in the regular care group (who achieved an average loss of just 1.3 percent of body weight) after 12 months. The lifestyle intervention group also reduced blood glucose levels by an average of over 4 mg/dl, from 105.8 mg/dl to 101.2 mg/dl, after 12 months, compared to an average drop of less than 2 mg/dl (to 104 mg/dl) for the regular care group. The results for the lifestyle group mirrored those achieved over three years by participants in the landmark National Institutes of Health-sponsored Diabetes Prevention Program, in which individuals with glucose levels in the pre-diabetic range were able to reverse the course of their disease by losing 5-7% of body weight and exercising 150 minutes per week, in addition to receiving individual counseling sessions with trained behavioralists. In the Diabetes Prevention Program, the weight loss program led to a 58% reduction in the development of diabetes, from about 11% a year to about 5% a year.

“In the Diabetes Prevention Program, professional behavioral specialists worked with participants with pre-diabetes in one-on-one sessions. We trained some of our patients with diabetes to work as lay community health workers with groups of participants with pre-diabetes, so we really didn’t expect to see quite as good a weight loss result as we did, but we were very pleased to see it,” said David Goff, MD, Chair of the Department of Epidemiology and Prevention at Wake Forest University School of Medicine, and lead researcher on the study. “Given that our weight loss results look as good as the DPP, this approach shows great promise for preventing diabetes. It’s a very translatable intervention to deliver in public health settings. We think this approach could be replicated at Diabetes Care Centers across the country.”

There are more than 3,000 such centers in the United States, with on-site physicians, diabetes educators and facilities that can be used for delivering the type of group intervention employed in this study. However, the intervention can be delivered in any setting where community health workers have access to a room large enough for about a dozen people to meet, a television, a DVD player, and a scale, Dr. Goff said.

The HELP PD model relies upon DVDs developed by the research team that give participants information about healthy eating, proper stretching and exercise tips, how to eat “mindfully” (i.e. not out of boredom or habitually in front of the television) and other lifestyle-related topics. Dr. Goff said that training community health workers to coach participants on how to set goals, solve problems and use the information in the DVDs could be accomplished by others interested in starting such a program in their own community. Reimbursement for these programs is a barrier.

Study participants will be followed for an additional five years to see whether individuals can maintain weight loss and blood glucose reductions independently, or if they need continued group counseling to do so. The study is being funded by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

HELP PD is one of numerous community-centered intervention models being developed based upon a program used during the DPP. Several different programs, tested in a variety of community settings, will be discussed and presented during the Association’s 70th Scientific Sessions, including the Group Lifestyle Balance Program, which helped significantly reduce diabetes risk factors through group settings at a primary care practice in California and also through DVDs that could be viewed at home (105-OR). This program was also successful when delivered by diabetes educators (417-PP). Another focused on Arab Americans in the Detroit, Michigan area, who successfully reached weight loss and physical activity goals through a program culturally modified to suit Middle Eastern diet and values (110-OR). And African Americans recruited during Sunday services at 42 churches in Georgia and Connecticut showed promising initial weight loss and a high willingness to participate in a church-based, culturally adapted lifestyle change program, according to preliminary data (109-OR).

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Oral Presentation, Tuesday, June 29, 8:25 a.m.

Contact:
Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Facilities And Providers

HHS Secretary Sebelius to Join Leaders From NIH, FDA and Academia to Discuss New Roles in Drug Discovery and Development

Posted on June 29, 2010 Written by Annalyn Frame

SOURCE: Ewing Marion Kauffman Foundation

KANSAS CITY, MO–(Marketwire – June 29, 2010) –  U.S. Secretary of Health and Human Services Kathleen Sebelius and other national leaders are coming together on July 6, 2010 for a first-of-its-kind town hall-style meeting with the goal of accelerating the discovery and development of new cancer drugs.

The event will bring together other senior government officials and thought leaders from industry, venture capital, academia, venture philanthropy and non-profit sectors to spur innovation and move discoveries more quickly from the laboratory to the clinic, where they can benefit patients battling cancer. Francis Collins, director of the National Institutes of Health, Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, and Richard Gephardt, former U.S. House Majority Leader and Chairman of the Council for American Medical Innovation, are among those who will participate.

Reflecting the growing shift away from the model of large pharmaceutical companies developing drugs internally from start to finish, the town hall is titled, “The New Role of Academia in Drug Discovery and Development.” It is being sponsored by Friends of Cancer Research and the University of Kansas Cancer Center, with support from the Kansas Bioscience Authority, Ewing Marion Kauffman Foundation and Council for American Medical Innovation.

Where: The Kauffman Foundation Conference Center, 4801 Rockhill Road, Kansas City, Mo., 64110

When: July 6, 2010, 7:45 a.m. – 3:45 p.m. CDT

Many key participants and organizational leadership will be available for press prior to the conference.

Press Contacts:
Friends of Cancer Research: Ryan Hohman, [email protected] or 717-333-6248

The University of Kansas Cancer Center: Marci Nielsen, [email protected], 913-961-0759 or Stephanie Sharp, [email protected], 913-579-4376

Kansas Bioscience Authority: Chad Bettes, [email protected] or 913-397-8300

Kauffman Foundation: Barb Pruitt, [email protected] or 816-932-1288

Council for American Medical Innovation: Sean Donahue, [email protected] or 202-347-7947

About Friends of Cancer Research

Friends of Cancer Research (Friends) is a cancer research think tank based in the Washington, D.C. area. Working with the entire cancer research and advocacy community, Friends pioneers innovative public-private partnerships, organizes critical policy forums, educates the public, and brings together key stakeholders to overcome the barriers standing between patients and the most promising cancer treatments.

About The University of Kansas Cancer Center

At The University of Kansas Cancer Center, we are more than an academic cancer center; we are a unique community-based cancer research and care partnership focused on one mission: eliminating the burden of cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program.

About the Ewing Marion Kauffman Foundation

The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. 

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, investment, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America’s economic recovery, future prosperity and health.

About the Kansas Bioscience Authority

The KBA is a $581 million initiative that is advancing Kansas’ national bioscience leadership by building world-class research capacity; fostering the formation and growth of bioscience startups; supporting expansion of the state’s bioscience clusters; and facilitating industrial expansion and attraction.

Press Contacts:
Friends of Cancer Research:
Ryan Hohman
[email protected]
717-333-6248

The University of Kansas Cancer Center:
Marci Nielse
[email protected]
913-961-0759

Stephanie Sharp
[email protected]
913-579-4376

Kansas Bioscience Authority:
Chad Bettes
[email protected]
913-397-8300

Kauffman Foundation:
Barb Pruitt
[email protected]
816-932-1288

Council for American Medical Innovation:
Sean Donahue
[email protected]
202-347-7947

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Vanguard Announces $225 Million Offering of Notes

Posted on June 29, 2010 Written by Annalyn Frame

SOURCE: Vanguard Health Systems, Inc.

NASHVILLE, TN–(Marketwire – June 29, 2010) –  Vanguard Health Systems, Inc. (“Vanguard”) announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC (“VHS Holdco II”), and Vanguard Holding Company II, Inc. (“VHS Holdco II Inc.” and, together with VHS Holdco II, the “Issuers”), plan to issue an aggregate principal amount of up to $225.0 million of 8% senior notes due 2018 (the “New Notes”) in a private placement. 

The Issuers intend to use the net proceeds from the offering of the New Notes, together with cash on hand, to finance Vanguard’s acquisition of substantially all of the assets of The Detroit Medical Center, a Michigan non-profit corporation, consisting primarily of eight acute care and specialty hospitals in the Detroit, Michigan metropolitan area and related healthcare facilities and to pay fees and expenses in connection with the foregoing. If the acquisition is not consummated, the proceeds of the offering of the New Notes will be used for general corporate purposes, including other acquisitions.

The New Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”). The New Notes may not be offered or sold within the United States or to U.S. persons, except to “qualified institutional buyers” in reliance on the exemption from registration provided by Rule 144A and to certain persons in offshore transactions in reliance on Regulation S. You are hereby notified that sellers of the New Notes may be relying on the exemption from the provisions of Section 5 of the Securities Act provided by Rule 144A. This announcement does not constitute an offer to sell or the solicitation of an offer to buy New Notes in any jurisdiction in which such an offer or sale would be unlawful.

Company Information and Forward Looking Statements

About Vanguard

Vanguard owns and operates 15 acute care hospitals with 4,135 licensed beds and complementary facilities and services in Chicago, Illinois; Phoenix, Arizona; San Antonio, Texas; and Massachusetts. Vanguard’s strategy is to develop locally branded, comprehensive healthcare delivery networks in urban markets. Vanguard will pursue acquisitions where there are opportunities to partner with leading delivery systems in new urban markets or to increase its presence in existing markets. Upon acquiring a facility or network of facilities, Vanguard implements strategic and operational improvement initiatives including expanding services, strengthening relationships with physicians and managed care organizations, recruiting new physicians and upgrading information systems and other capital equipment. These strategies improve quality and network coverage in a cost effective and accessible manner for the communities Vanguard serves.

This press release contains “forward-looking statements” within the meaning of the federal securities laws which are intended to be covered by the safe harbors created thereby. Forward-looking statements are those statements that are based upon management’s current plans and expectations as opposed to historical and current facts and are often identified in this report by use of words including but not limited to “may,” “believe,” “will,” “project,” “expect,” “estimate,” “anticipate,” and “plan.” These statements are based upon estimates and assumptions made by Vanguard’s management that, although believed to be reasonable, are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. These factors, risks and uncertainties include, among others, Vanguard’s high degree of leverage and interest rate risk; Vanguard’s ability to incur substantially more debt; operating and financial restrictions in Vanguard’s debt agreements; the enactment in March 2010 of major healthcare reform legislation and the future possible enactment of additional federal or state health care reform and changes in federal, state or local laws or regulations affecting the healthcare industry; Vanguard’s ability to generate cash necessary to service Vanguard’s debt; weakened economic conditions and volatile capital markets; post-payment claim reviews by governmental agencies could result in additional costs to us; Vanguard’s ability to successfully implement Vanguard’s business strategies; Vanguard’s ability to grow its business and successfully integrate future acquisitions, including the assets of The Detroit Medical Center; potential acquisitions, including the assets of The Detroit Medical Center, could be costly, unsuccessful or subject Vanguard to material unexpected liabilities; conflicts of interest that may arise as a result of Vanguard’s control by a small number of stockholders; the highly competitive nature of the healthcare industry; governmental regulation of the industry, including Medicare and Medicaid reimbursement levels; pressures to contain costs by managed care organizations and other insurers and Vanguard’s ability to negotiate acceptable terms with these third party payers; Vanguard’s ability to attract and retain qualified management and healthcare professionals, including physicians and nurses; future governmental investigations; the availability of capital to fund Vanguard’s corporate growth strategy; potential lawsuits or other claims asserted against Vanguard; Vanguard’s ability to maintain or increase patient membership and control costs of its managed healthcare plans; Vanguard’s exposure to the increased amounts of and collection risks associated with uninsured accounts and the co-pay and deductible portions of insured accounts; dependence on Vanguard’s senior management team and local management personnel; volatility of professional and general liability insurance for Vanguard and the physicians who practice at its hospitals and increases in the quantity and severity of professional liability claims; Vanguard’s ability to maintain and increase patient volumes and control the costs of providing services, including salaries and benefits, supplies and bad debts; increased costs from further regulation of healthcare and potential liability from Vanguard’s failure to comply, or allegations of Vanguard’s failure to comply, with applicable laws and regulations; the geographic concentration of Vanguard’s operations; Vanguard’s failure to adequately enhance Vanguard’s facilities with technologically advanced equipment; technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for, healthcare services and shift demand for inpatient services to outpatient settings; costs and compliance risks associated with Section 404 of the Sarbanes-Oxley Act; a failure of Vanguard’s information systems that would adversely impact its ability to manage its operations; material non-cash charges to earnings from impairment of goodwill associated with declines in the fair market values of Vanguard’s reporting units; and volatility of materials and labor costs for potential construction projects that may be necessary for future growth.

Although Vanguard believes that the assumptions underlying the forward-looking statements contained in this press release are reasonable, any of these assumptions could prove to be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, you should not regard the inclusion of such information as a representation by Vanguard that its objectives and plans anticipated by the forward-looking statements will occur or be achieved, or if any of them do, what impact they will have on Vanguard’s results of operations and financial condition. Vanguard undertakes no obligation to publicly release any revisions to any forward-looking statements contained herein to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.

Contact:
Vanguard Health Systems, Inc.
Gary Willis
Senior Vice President and Chief Accounting Officer
(615) 665-6098

Filed Under: Facilities And Providers

StayWell Custom Communications Aligns With Leading SEO Firm to Offer Search Engine Marketing Services

Posted on June 29, 2010 Written by Annalyn Frame

SOURCE: StayWell Custom Communications

SALT LAKE CITY, UT–(Marketwire – June 29, 2010) –  Custom health communications company StayWell Custom Communications (SCC), a division of MediMedia USA, has announced an exclusive strategic alliance with SEO.com, a leading provider of search marketing strategies including search engine optimization, pay-per-click management, social media, and SEO Web design. 

Through this strategic alliance, StayWell Custom Communications will be offering a range of search marketing strategies designed to increase website traffic, build loyal customers and drive online transactions for its clients, which include health care providers, health plans, and retailers such as pharmacies and supermarket chains.

The increasing demand for online health information and services is fueling a growing need for health care organizations and health care retailers to focus on programs and tactics that make it easier for consumers to navigate the Internet and find information, which ultimately builds business for their organization. Search Engine Optimization and online advertising programs are becoming an increasingly important part of the mix when it comes to driving prospective patients and consumers to a health care site.

“As organizations continue to invest heavily in developing a robust online presence, ensuring that consumers can find them is critical to a successful e-business strategy,” said StayWell Custom Communications president and CEO Trent Sterling. “The need for such specialized search marketing strategies in order to optimize healthcare content and services have become ever more important.”

SCC established the alliance with SEO.com in order to meet this need and help its clients improve site performance. “We partner with our clients to deliver robust interactive health content solutions designed to achieve business results,” said Sterling. “The excellent search marketing strategies offered by SEO.com will enable our clients to maximize their ROI by helping them boost their Web traffic, and turn that traffic into revenue for their organization. With 80 percent of consumers going online to look for health information, the potential for our clients to use their content to attract visitors is unlimited.” 

SEO.com, an SEO company, is based just outside Salt Lake City, just minutes away from the headquarters of SCC’s Interactive Solutions. SEO.com’s clients include Dell, H&R Block, AlphaGraphics, Hugo Boss and Mrs. Field’s Cookies. Website Magazine ranked SEO.com the No. 2 SEO firm in the country in April 2010.

“Good content with the right keywords is critical for search engine optimization,” said Dave Bascom, CEO of SEO.com. “We’re excited to have joined forces with StayWell to help many respected organizations in the health industry achieve their goals.”

About StayWell Custom Communications (SCC)
StayWell Custom Communications is the leader in custom health content solutions delivered via a variety of sophisticated technology platforms. Our interactive offerings include robust web platforms, online health libraries, e-mail and SMS (or mobile) marketing programs, and an extensive range of multimedia tools including video, podcasts and animations. The company serves hundreds of clients representing several channels in the healthcare industry: hospitals and health systems; health plans; employers; and retail organizations. StayWell Custom Communications also offers a comprehensive range of print and print/interactive integrated solutions to meet a broad range of clients’ marketing and communication needs. 

SCC is a member of the StayWell family of companies, which includes Krames, StayWell Health Management, StayWell Consumer Health Publishing (A Harvard Medical School Strategic Alliance), Vitality Communications, StayWell Productions and StayWell Safety Solutions (a Red Cross Strategic Business Alliance). StayWell, which is a division of MediMedia USA, represents the largest patient education and consumer health information publisher in North America.

For more information, visit www.staywellcustom.com.

About MediMedia
Headquartered in Yardley, PA, with 1,700 employees in offices throughout the U.S., MediMedia changes consumer and professional behaviors through superior engagement, education and end-user preferences. Our health information services group creates, publishes, distributes, and syndicates on and off-line health information to help consumers make informed health decisions on behalf of a variety of sponsors, including providers — both hospitals and physicians, payers, and online media companies. Our health management services group provides population health management services which help consumers lower their health risk, enabling employers to lower their risks, utilization and ultimately their health care expenses. And finally, our professional segment derives its revenues from providing online/off-line professional promotion, engagement, and education services targeted to healthcare professionals and their patients.

MediMedia is a Vestar Capital Partners portfolio company.

About SEO.Com
SEO.com is a search marketing firm that makes its clients money by driving traffic to their websites through aggressive search engine optimization, pay per click management, and social media marketing. SEO.com then turns those visitors into sales through search-optimized Web design and conversion optimization. Clients range from small startups to Fortune 100 companies. For more information, visit http://www.seo.com/.

For more information:
Angie Hansen
StayWell Custom Communications
(801) 517-6941
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Southern Chicago Healthcare Provider, Riverside Healthcare, Launches New Website

Posted on June 29, 2010 Written by Annalyn Frame

SOURCE: Riverside Medical Center

KANKAKEE, IL–(Marketwire – June 29, 2010) –  Riverside Healthcare is proud to have their new website up and running. Current users of www.RiversideHealthcare.org will notice that the new website has maintained the overall look and feel of the original site and also offers new information in an easy to navigate format. As one of the top hospitals in Illinois, this website only makes Riverside’s services that much better.

With just a quick visit to this website you will see that they offer a wide range of services online. This Chicago south suburbs healthcare provider allows you to find a physician online with a basic search. Whether you need a dentist, family doctor, oncologist or even a plastic surgeon, this website can help you find one. If you need to schedule a mammogram or bone density scan, you can make this appointment directly online. There is no need to make telephone call and wait on hold anymore. Simply logon to get started today.

We all know that paying our medical bills can get hectic at times. Through Riverside Healthcare’s new website you can pay your medical bills with their bill payment center. This system makes paying your bills simple and convenient.

If you are not a patient at the hospital, but know someone staying at the southern Chicago healthcare center, there are services online that can help you as well. This website is great for those people who live out of town and can’t make it to the hospital to be there in person. You can go online and order flowers to be sent to your loved one. You can choose from a wide range of beautiful arrangements that will be delivered directly to their room. The website also offers access to The Market Place, where you can shop for all different types of medical goods. If you need books, gifts, strollers, or vitamins, this website has it all. One of the most popular features of the website is the online nursery. If someone you are close to just had a baby you can access the online nursery through their website as well.

Riverside Healthcare’s new website has something to offer everyone. You can visit the website every day to read up on the latest medical news. www.RiversideHealthcare.org is just what the doctor ordered!

Media Contact:
Carl Maronich
815-935-7256
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Medical Women’s International Association: Good Maternal Health Care Must Be Maintained in Order to Save Thousands of Lives

Posted on June 28, 2010 Written by Annalyn Frame

VANCOUVER, BRITISH COLUMBIA–(Marketwire – June 28, 2010) – Funding for maternal health care must stay front and centre as the G8 and G20 summits conclude. Approximately 500,000 women around the globe die each year from pregnancy related causes that are preventable. Another 70,000 die from complications of unsafe abortions. When their mothers die, 80% of children under age one will also die, usually within two years.

Prime Minister Stephen Harper demonstrated Canadian leadership when addressing the goal of improving maternal health and lowering maternal and child mortality. Women around the world need Canada’s commitment and that of the other G8 countries.

As physicians, we are committed to evidence based solutions and realize that to reach this goal the strategy must include access to a full range of reproductive health programs including access to safe abortion where legal. There must be development of strong health care systems, supported by trained health care providers and integrated into whichever local health systems already exist. There need to be community based programs for maternal and child health including preventative programs such as nutrition, public health and vaccination programs. There also need to be programs that continue to work on the big three diseases that ravage sub-Saharan Africa, namely TB, malaria and HIV/AIDS, as these diseases contribute significantly to maternal and child mortality.

As world leaders leave Canada and prepare for the upcoming meeting in South Korea, there needs to be a commitment from all G8 countries for $30 billion over five years to fund maternal health. Saving women makes economic sense. Women make up half of the world’s population, and as women, produce the other half.

The Medical Women’s International Association has been in existence since 1919 and is an organization of women physicians from around the world whose mandate is to improve the health of women and children. The national branch is the Federation of Medical Women of Canada.

Filed Under: Facilities And Providers

Diabetes Drug Rosiglitazone Not Associated With Increased Risk of Death, Stroke or Heart Attacks in BARI 2D Study

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

Study Confirms Higher Incidence of Fractures

ORLANDO, FL–(Marketwire – June 28, 2010) –  Rosiglitazone, a commonly used diabetes drug, poses no significant increased risk of death, stroke or heart attack, though it does increase the risk of fractures, according to a new analysis of thousands of patients with established cardiovascular disease and type 2 diabetes. The findings are being presented at the American Diabetes Association’s 70th Scientific Sessions®, and are part of the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) study, a landmark multicenter trial focusing exclusively on patients with both diabetes and established heart disease.

The safety of rosiglitazone, marketed as Avandia, a medication in the class of thiazolidinedione (TZD) drugs, has been a controversial topic since a 2007 meta-analysis published in the New England Journal of Medicine concluded that rosiglitazone “was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes.” The strength of this study, which reviewed the results of 42 previously published investigations but did no independent testing of the drug, has been questioned by others in the field but ultimately led to a review of the drug’s safety by the U.S. Food and Drug Administration (FDA). In November 2007, the FDA added a warning label to the drug regarding potential heart risks.

The following year, however, researchers conducting the Veterans Affairs Diabetes Trial (VADT), a large-scale clinical trial in which 80 percent of patients were taking rosiglitazone, added further, while still inconclusive, information to this discussion. During the American Diabetes Association’s 68th Scientific Sessions, the VADT researchers reported that a specific analysis of rosiglitazone found that it did not appear to cause excess cardiovascular events and may in fact provide protective benefits for cardiovascular health.

Now a post-hoc analysis of the BARI 2D findings also shows no increased risk of heart attack or cardiovascular death with rosiglitazone treatment. Analyzing 4.5 years of follow-up data for patients who were being treated with rosiglitazone, compared to those not taking any TZD drugs, the study found no increase in risk of death or heart attack from taking rosiglitazone. While no protective cardiovascular benefit was shown, the analysis found that the rate of death, heart attack and stroke tended to be lower — about 28 percent lower in fact — among patients taking rosiglitazone. As has been seen with other studies of TZDs, the rate of congestive heart failure was significantly higher among patients taking rosiglitazone, but this difference was not statistically significant. 

As seen in previous studies, the analysis of BARI 2D reported a 45 percent increase in fracture rates for those taking rosiglitazone, compared to those not taking any TZD medications.

“I think these data are important because they suggest there is no significant cardiovascular harm posed by taking rosiglitazone for patients with type 2 diabetes and coronary heart disease,” said lead researcher Richard Bach, M.D., Associate Professor of Medicine at the Washington University School of Medicine. “There is an increase in fractures, but when one considers the dramatic morbidity and mortality associated with ischemic cardiovascular events in patients with diabetes, these data are reassuring.”

The BARI 2D study, led by principal investigator Sheryl Kelsey, Ph.D, of the University of Pittsburgh Graduate School of Public Health, evaluated both a cardiovascular treatment approach as well as a diabetes control approach in 2,368 persons with type 2 diabetes and stable coronary artery disease (CAD) to reduce deaths or deaths and cardiovascular events (heart attacks and stroke) combined. The first component compared intensive medical treatment with prompt coronary revascularization by either bypass surgery or angioplasty (which opens blocked arteries by inserting metal stents or balloons through the arteries, without recourse to surgery) to intensive medical treatment alone. The second component compared whether controlling diabetes with drugs to make insulin work better (insulin sensitization) had an advantage for heart health or survival compared to using a strategy emphasizing drugs increasing insulin itself (insulin provision).

Nearly 24 million Americans have diabetes, a group of serious diseases characterized by high blood glucose levels that result from defects in the body’s ability to produce and/or use insulin. Diabetes can lead to severely debilitating or fatal complications, such as heart disease, stroke, blindness, kidney disease and amputation. It is a leading cause of death by disease in the United States. Type 2 diabetes involves insulin resistance — the body’s inability to properly use its own insulin — and occurs mainly in adults who are overweight and age 40 and older. More than 65 percent of people with diabetes die from heart disease or stroke. With diabetes, heart attacks occur earlier in life and often result in death.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Oral presentation, Tuesday, 8:50 a.m.

Contact:

Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Facilities And Providers

FMX Ventures Announces Appointment of New CFO

Posted on June 28, 2010 Written by Annalyn Frame

TORONTO, ONTARIO–(Marketwire – June 28, 2010) – FMX Ventures Inc. (the “Company“) (TSX VENTURE:FXX.H)announced today that, subject to regulatory approval, it has appointed Mr. Carmelo Marrelli as its Chief Financial Officer. Mr. Marrelli replaces Jon Kelly who has resigned to pursue other interests. Mr. Kelly served as Chief Financial Officer of the Company prior to the sale of its orthotics business in 2007 and assisted with the Company’s transition from an operating company to its current form. The board of directors of the Company wishes to thank Mr. Kelly for his contributions.

Mr. Marrelli holds a Bachelor of Commerce degree from the University of Toronto and is a qualified Chartered Accountant and Certified General Accountant. Mr. Marrelli is currently President of Marrelli Support Services, a bookkeeping firm based in Toronto, Ontario.

Number of Common Shares Outstanding – 3,934,296

Filed Under: Facilities And Providers

American Diabetes Association Revised Embargo for Rosiglitazone Study

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

ORLANDO, FL–(Marketwire – June 28, 2010) –  The American Diabetes Association has announced a change in the embargo time of the rosiglitazone study being presented at the 70th Scientific Session in Orlando, FL. This is part of the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) study, a landmark multicenter trial focusing exclusively on patients with both diabetes and established heart disease. The new embargo time is 4:30 pm (EDT).

The American Diabetes Association thanks the BARI 2D investigators for their collaboration and appreciates their willingness to present this important scientific information to the diabetes community during the 70th Scientific Sessions. The full scientific disclosure and discussion of these data will be featured at the Late Breaking Clinical Trials session on Tuesday, June 29, 2010 at 8:50 am.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Christine Feheley
Newsroom: 407-685-4010
Office: 703-253-4374

id=”nav_links”>

Filed Under: Facilities And Providers

GuideStar Advises That June 30 Fiscal Year End Will Trigger New Form 990 Filing Deadline for Many Nonprofits

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: GuideStar USA, Inc.

Failure to File May Lead to Loss of Tax-Exempt Status

WASHINGTON, DC and WILLIAMSBURG, VA–(Marketwire – June 28, 2010) –  GuideStar, the leading source of nonprofit information, encourages any exempt organization whose fiscal year ends June 30 to verify that it is compliant with IRS reporting requirements in order to maintain its exemption.

Most tax-exempt organizations except churches are required to file an annual information return (IRS Form 990-N, 990-EZ, 990, or 990-PF). Organizations required to file that fail to do so for three consecutive years will automatically lose tax-exempt status, as mandated by a provision of the Pension Protection Act of 2006. 

The deadline for filing Form 990 and its variants is determined by the end of the filing organization’s fiscal year. The filing deadline for an organization whose fiscal year ends on June 30, 2010, is November 15, 2010. 

“The first time the revocation provision of the Pension Protection Act was put in effect was last May, when returns for organizations whose fiscal year ended December 31, 2009, were due,” said Bob Ottenhoff, GuideStar’s president and CEO. “We learned then that thousands of nonprofits, particularly smaller ones, did not realize they needed to file and were at risk of losing their exemptions. That’s why GuideStar created a nonprofit resource center about the revocations. Nonprofits can use the resource center to stay up to date on what they must do in terms of filing an annual information return.”

An organization’s annual gross revenue and assets determine which version of the 990 it must file. Filing extensions are available for Forms 990-EZ, 990, and 990-PF, but not for Form 990-N. (See the accompanying table.)

GuideStar’s nonprofit resource center provides an overview of the revocations issue and several quick links, including ones to a Form 990-N filing status database, the mechanics of filing Form 990-N, filing exceptions, filing thresholds, filing deadlines and extensions, and IRS and GuideStar revocation FAQs. The resource center is updated as new developments related to the revocations occur.

“We hope every exempt organization will use these resources to ensure that they are not at risk of losing their exemptions for failure to file an annual return,” Ottenhoff said. “Nonprofits play vital roles in our society, and losing tax-exempt status will hurt not only the organizations but also the causes and people they serve.” 

About GuideStar

GuideStar, www.guidestar.org, connects people and organizations with information on the programs and finances of more than 1.8 million IRS-recognized nonprofits. GuideStar serves a wide audience inside and outside the nonprofit sector, including individual donors, nonprofit leaders, grantmakers, government officials, academic researchers, and the media.

News Contact
Suzanne E. Coffman
Director of Communications
(757) 941-1427
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

TetriDyn Solutions, Inc. Introduces Charge Catcher at Bear Lake Memorial and Steele Memorial Hospitals

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: TetriDyn Solutions, Inc.

POCATELLO, ID–(Marketwire – June 28, 2010) –  TetriDyn Solutions, Inc. (OTCBB: TDYS), a multi-channel technology innovator in the Information Technologies sector, announced today that it has delivered its latest revenue and business process improvements tool targeted specifically for hospital environments — Charge Catcher.

Charge Catcher enables hospitals to improve their revenue generation by identifying lost charges in an accurate and timely manner. Hospitals can improve their revenue by reviewing and correcting the identified and missed charges quickly and accurately. Charge Catcher uses a combination of rule-based logic and artificial intelligence techniques to detect potential missing charges before the patient bill is generated. 

Bear Lake Memorial Hospital increased its earnings by more than one percent of gross revenues in its first full year of using Charge Catcher. Bear Lake Memorial Hospital also found additional benefits of using Charge Catcher included lower administrative costs due to fewer re-billings, improvements in departments’ billings and procedures, and enhanced levels of compliance. TetriDyn has also recently signed a contract with Steele Memorial Medical Center to implement the latest version of Charge Catcher in their facility so that they can begin to appreciate increased revenues as well.

In addition, past charges can be reviewed in the initial stages of deployment to recoup lost revenue from previous billing cycles as much as one year later. Charge Catcher has been proven to incrementally increase revenue reimbursement, improve billing accuracy, and reduce business office expenses.

Dave Hempstead, CEO of TetriDyn Solutions, commented, “We are excited to be delivering to our customers a product that generates added revenue on a daily basis. The Charge Catcher tool creates revenue improvements for hospitals and reduces accounts receivable days throughout the revenue cycle.” 

For more information about Charge Catcher, visit www.chargecatcher.com.

About TetriDyn Solutions, Inc.
TetriDyn Solutions, Inc. (OTCBB: TDYS) specializes in providing business information technology (IT) solutions to its customers. TetriDyn Solutions optimizes business and IT processes by utilizing systems engineering methodologies, strategic planning, and system integration to add efficiencies and value to its customers’ business processes and to help its customers identify critical success factors in their business. For more information about the company, visit www.tetridyn.com.

For Further Information:
Phone 208-232-4200
Public Relations
TetriDyn Solutions, Inc.

Filed Under: Facilities And Providers

Uni-Ter Names Vilches VP-Marketing

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: Uni-Ter Underwriting Management Corp.

ATLANTA, GA–(Marketwire – June 28, 2010) –  Armando L. Vilches, CPCU, a sales executive with 25 years of experience in property/casualty insurance, has joined Uni-Ter Underwriting Management Corporation as Vice President-Marketing, Nadeene Wood-Clater, Senior Vice President-Marketing, announced.

Vilches spent 20 years with the Willis Insurance Group and its subsidiary Stewart Smith where he was named the Company’s Most Valuable Producer in 2000. As Nashville Marketing Manager, he led a team that placed $250 million in commercial premium.

“Armando has an outstanding track record marketing and underwriting all lines of liability insurance. He will be a valuable addition to the Uni-Ter team as the Company grows,” Wood-Clater said.

Vilches will work in marketing and new business development for Lewis & Clark LTC RRG, Inc., provider of liability insurance to long-term care facilities and nurses nationwide and Ponce de Leon LTC RRG, Inc. that writes liability insurance for long-term care facilities in Florida. He will work also on new business development for J.M. Woodworth Risk Retention Group, Inc., medical malpractice insurance writer in New York, Connecticut, New Jersey, and Pennsylvania.

Vilches is a graduate of DePaul University. He holds the CPCU (Chartered Property Casualty Underwriter) Designation and is a recognized speaker on risk management and liability insurance.

Learn more about Uni-Ter at www.uni-ter.com.

Media contact:
Mechlin Moore
MDM Communications
239-777-1595
Email Contact

Filed Under: Facilities And Providers

New Medline.com Website Offers Faster Product Search With Highly Intuitive, User-Friendly Enhanced Features

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: Medline Industries, Inc.

New Site Increases Product Search Performance by More Than 50 Percent

MUNDELEIN, IL–(Marketwire – June 28, 2010) –  Medline Industries, Inc., the nation’s largest privately held manufacturer and distributor of medical supplies, today announced the launch of a new, completely redesigned and expanded company website that vastly improves the user experience for its healthcare customers. The newly revamped medline.com features improved navigation enabling direct access to key information regarding Medline products, programs and education.

“While we’ve refined the design, we’ve also improved the use of technology so users can engage directly with our content, products and services faster than ever,” said Jignesh Thakkar, Medline’s Director of E-Business Marketing. “The redesigned website vastly improves the customer experience. Visitors can now get much more information quickly and easily through expanded content, videos, product search capabilities and more.”

With users accessing medline.com content more than two million times a month, a critical outcome for the redesign was to not only create an updated interactive environment for customers, but to help them find what they are looking for easier and faster. The new site achieves this by not only increasing product search performance by more than 50 percent, but by also adding more features such as:

  • 200-plus pages of fresh content that provides valuable information and resources to customers.
  • Thousands of additional product images and updated descriptions
  • New detailed product specification pages — in full page format
  • Ability to select preferred product page views in thumbnail, column or table formats
  • Filtered product category functionality to reduce product search results
  • Selection categories of top products and manufacturers from the products results page.

“It is so much more user friendly. I like the options at the top (thumbnails) as to how you can view the items,” said Cali Yocom of Bethany Hospice in Valdosta, GA. “I also love the pictures. It is so nice to have that when you want to get a better view of the item.”

The medline.com redesign is the second major upgrade the company has made to its core group of websites. Last month significant enhancements were added to Medline University (MU), its online resource for clinical education and product training for healthcare providers. That site (www.medlineuniversity.com) now includes free unlimited access to CE credit courses, live webinars, downloadable podcasts, real-time news feeds and innovative interactive competency tools. Additionally, the company also recently added a free CE iPhone® and iPod Touch® app, now available for download from Apple’s iTunes store.

“Medline is committed to helping customers make profitable, educated decisions through engaging, interactive experiences,” said Mike Penny, Medline Chief Information Officer. “Our focus on innovation in online interaction will continue to increase over time as we see strong results from our efforts to date.”

About Medline Industries, Inc.

Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline Media Contacts:
Jerreau Beaudoin
(847) 643-3011
John Marks
(847) 643-3309

Filed Under: Facilities And Providers

GetWellNetwork Webinar Shares Secrets to High Patient Satisfaction for Children’s Hospitals

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: GetWellNetwork, Inc.

BETHESDA, MD–(Marketwire – June 28, 2010) –  GetWellNetwork, Inc. will host a webinar on Tuesday, June 29th to demonstrate how children’s hospitals can improve patient satisfaction and enhance patients’ and families’ experience through using GetWell Town™, an interactive patient care solution.

GetWell Town was developed in collaboration with GetWellNetwork’s National Children’s Hospital Task Force, comprised of 15 pediatric facilities across the U.S., and direct input from pediatric patients and their families. GetWell Town is designed to complement the kid-friendly spaces that children’s hospitals have worked hard to create and features exclusive content in partnership with KidsHealth®, part of The Nemours Foundation’s Center for Children’s Health Media.

“Since the launch of GetWell Town, we’ve been honored to help many pediatric facilities improve patient care processes and drive better outcomes as a result,” said Shannon O’Neil, MSW, Director of Pediatrics at GetWellNetwork, Inc. “This webinar is designed to share with other children’s hospitals how they can realize the same benefits for their patients and gain efficiencies in core nursing activities such as education, patient documentation, and patient safety.”

To register for this webinar please visit http://www.getwellnetwork.com/webinar.asp.

When: June 29, 2010.
Time: 12:00-1:00 PM, EDT.
Who: Chief Nursing Officers, Child Life Specialists, Discharge Planners, Environmental Services, and Safety Services.

More information about GetWell Town is available at http://www.getwellnetwork.com/pdfs/getwell_town.pdf.

About GetWellNetwork
GetWellNetwork, Inc. uses the bedside TV to entertain, educate and empower hospital patients and caregivers to be more actively engaged in their care. This patient-centered approach improves both satisfaction and outcomes for patients and hospitals. GetWellNetwork is the leader in interactive patient care solutions and exclusively endorsed by the American Hospital Association. More information about GetWellNetwork can be found at www.GetWellNetwork.com.

Media Contact:
Jenny Song
(703) 338-8434
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

ALR Technologies Appoints Healthcare Executive as President and Chief Operating Officer

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: ALR Technologies Inc.

Lawrence Weinstein Brings Extensive Healthcare Industry Experience

ATLANTA, GA–(Marketwire – June 28, 2010) – ALR Technologies Inc. (OTCBB: ALRT) announces the appointment of Lawrence (Larry) Weinstein to be President and Chief Operating Officer effective July 1, 2010, replacing Sidney Chan who will become Chairman and Chief Executive Officer. Stan Cruitt is retiring as Chairman of the Company.

Larry has extensive experience in the development and launch of medical products. His experience includes 11 years with Cordis Corporation (a Johnson & Johnson company), 6 years with DHD Healthcare Corporation and most recently, 9 years with Pari Respiratory Equipment. He is leaving Pari as Senior Vice President of Operations at PRE Holding, Inc. and as President, Hydrate, Inc.

Mr. Chan says that, “Larry Weinstein brings a skill set and experience that will be invaluable as the company introduces the ALRT Health-e-Connect (HeC) monitoring system. Our product will be invaluable for the healthcare industry to achieve better health outcomes and contain costs.”

About ALR Technologies Inc.
ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web-based application for medical professionals to improve compliance and adherence of care plans of patients in their homes. HeC is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at http://www.alrt.com. 

This release contains certain “forward-looking statements” relating to ALR Technologies’ business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words “estimate,” “expect,” “anticipate,” “believe” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company’s quarterly filings with the Securities Exchange Commission.

Public Relations:
ALR Technologies Inc.
678-881-0002 Ext. 704
e-mail: Email Contact

Filed Under: Facilities And Providers

MedChoice Financial Adds New Capabilities in Its Platinum Provider Portal to Support Healthcare Practices

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: MedChoice Financial

Provides Dental, Cosmetic, Laser Hair Removal/Restoration, and Medical Practitioners With Automated Processes, New Reporting Features and Increased Efficiencies

DEERFIELD BEACH, FL–(Marketwire – June 28, 2010) –  MedChoice Financial, a national medical financial company, announces new functionality for healthcare and medical providers to truly leverage its Platinum Provider Portal and go paperless. The secure, web-based provider portal enables a medical practice or clinic to dynamically manage its financing programs through automated processes, application submissions and reporting.

The portal now allows for more visibility into the current state of a patient’s account by showing in real time availability of funds. Healthcare providers can service patients faster when they know what funds can be applied to their patients’ procedures, whether it be medical, cosmetic, dental, laser hair removal or restoration. Additionally, MedChoice’s enhanced reporting benefits practices by allowing them to export data to an Excel spreadsheet and allows for the integration with other business applications.

“The enhancements we have made to our portal support our mission for a customer driven, flexible and responsive support system for a practice’s needs. Our investment in automation will benefit practices nationwide by not having to delay performing procedures and will give them an instant overview of a patient’s financing options,” said Valerie Harding, MedChoice Financial Marketing Spokesperson.

Healthcare practices today find physicians and their staff juggling more patients and paperwork, with fewer resources. MedChoice’s Platinum Provider Portal simplifies, accelerates and automates administrative tasks that drain precious resources. It allows staff and physicians to focus their energies on better serving their patients and brings the practice one step closer to achieving a paperless environment. Other benefits include increased efficiencies and accuracies, improved access to information, better collaboration and communication between colleagues and patients.

About MedChoice Financial

MedChoice Financial, headquartered in Deerfield Beach, FL, is a national medical financial institution that services the medical community (medical, dental, cosmetic) and its patients with flexible, convenient financing solutions. Dedicated foremost to superior customer service and partnered with World Financial Network National Bank (WFNNB), MedChoice Financial has become one of the largest and fastest growing elective medical financing companies in the nation. For more information, visit www.medchoicefinancial.com

Media Contact:
Valerie Harding
Ripple Effect Communications
Tel: 617-536-8887
Email: Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Presentation of preclinical data for NicOx’s ophthalmology candidate NCX 434

Posted on June 28, 2010 Written by Annalyn Frame

SOURCE: NICOX

SOPHIA ANTIPOLIS, FRANCE–(Marketwire – June 28, 2010) – www.nicox.com

NicOx S.A. (NYSE Euronext Paris: COX) today announced that new preclinical
results for NCX 434 were presented at the Retina International World
Congress in Stresa, Italy. NCX 434 is a nitric oxide (NO)-donating new
molecular entity (NME) and a potential preclinical candidate in Diabetic
Macular Edema (DME). It was shown to reduce retinal damage due to ischemia
(restriction of blood flow) and reperfusion (return of blood supply
following ischemia) in a preclinical model without inducing a significant
increase of intraocular pressure (IOP), in contrast to a reference steroid.

DME is a form of diabetic retinopathy, which results from high blood sugar
causing progressive damage to retinal cells and can lead to blindness. In
addition to laser surgery, DME is often treated with injections of steroids
inside the eye (intravitreal injections), which tend to increase IOP,
presenting a significant safety concern. Additionally, local ischemia
resulting from an imbalance between NO, known for its vasodilation
properties, and a vasoconstrictor substance called endothelin-1 (ET-1)
appears to play a pivotal role in DME progression.

This presentation showed that NCX 434 was efficient in reducing several
biochemical and functional aspects of retinal damage in a preclinical model
of ischemia/reperfusion induced by the injection of ET-1. NCX 434 did not
significantly change IOP in this model, while triamcinolone acetonide, a
reference steroid, resulted in significant increase in IOP.

Previous preclinical results showing that NCX 434 enhanced oxygen
saturation in various optic nerve head structures in contrast to a
reference steroid were presented recently at the Ocular Diseases & Drug
Discovery conference in Boston (NicOx press release dated June 1, 2010).

Risks factors which are likely to have a material effect on NicOx’s
business are presented in the 4th chapter of the ” Document de
référence, rapport financier annuel et rapport de gestion 2009 ”
filed with the French Autorité des Marchés Financiers (AMF) on
March 5, 2010 and available on NicOx’s website (www.nicox.com) and on the
AMF’s website (www.amf-france.org).

The Company notably draws the investors’ attention to the following risk
factors:

– Risques liés à la dépendance de la Société
à l’égard du naproxcinod (Risks related to the Company’s
dependence on the success of its lead product naproxcinod)

– Risques commerciaux et développements cliniques (Clinical
developments and commercial risk)

– Risques liés aux contraintes réglementaires et à la
lenteur des procédures d’approbation (Risks linked to regulatory
constraints and slow approval procedures)

– Manque de capacités dans les domaines de la vente et du marketing
(Lack of sales and marketing capabilities)

– Incertitude relative aux prix des médicaments et aux régimes de
remboursement, ainsi qu’en matière de réforme des régimes
d’assurance maladie (Uncertainty on drug pricing and reimbursement policies
and on the reforms of the health insurance systems)

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a pharmaceutical company
focused on the research, development and future commercialization of drug
candidates. NicOx is applying its proprietary nitric oxide-donating R&D
platform to develop an internal portfolio of New Molecular Entities (NME)
for the potential treatment of inflammatory, cardio-metabolic and
ophthalmological diseases.

NicOx’s lead investigational compound is naproxcinod, an NME and a first-
in-class CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-
inflammatory drug candidate developed for the relief of the signs and
symptoms of osteoarthritis (OA), which is currently under review by
regulatory authorities, following the submission and filing of a New Drug
Application (NDA) to the US Food and Drug Administration (FDA) and a
Marketing Authorization Application (MAA) to the European Medicines Agency
(EMA). The FDA and the EMA are evaluating the data submitted. The FDA has
set an action date of July 24, 2010, under the Prescription Drug User Fee
Act (PDUFA).

In addition to naproxcinod, NicOx’s pipeline includes several nitric oxide-
donating NMEs, which are in development internally and with partners,
including Merck & Co., Inc. and Bausch + Lomb, for the treatment of
hypertension, cardiometabolic diseases, eye diseases and dermatological
diseases.

NicOx S.A. is headquartered in France and is listed on Euronext Paris
(Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although
the Company believes its expectations are based on reasonable assumptions,
these forward-looking statements are subject to numerous risks and
uncertainties, which could cause actual results to differ materially from
those anticipated in the forward-looking statements.

For a discussion of risks and uncertainties which could cause actual
results, financial condition, performance or achievements of NicOx S.A. to
differ from those contained in the forward-looking statements, please refer
to the Risk Factors (“Facteurs de Risque”) section of the Document de
Reference filed with the AMF, which is available on the AMF website
(http://www.amf-france.org) or on NicOx S.A.’s website
(http://www.nicox.com).

CONTACTS

www.nicox.com

NicOx

Gavin Spencer – Vice President Business Development

Tel +33 (0)4 97 24 53 00 – [email protected]

Media Relations

Financial Dynamics

Europe

Guillaume Granier (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Stéphanie Bia (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Jonathan Birt (UK) – Tel +44 (0)20 7269 7205 – [email protected]

United States

Robert Stanislaro – Tel +1 212 850 5657 – [email protected]

Irma Gomez-Dib – Tel +1 212 850 5761 – [email protected]

NicOx S.A.,

Les Taissounières – Bât HB4 – 1681 route des Dolines – BP313,
06906 Sophia Antipolis cedex, France. Tel. +33 (0)4 97 24 53 00 – Fax +33
(0)4 97 24 53 99

This information is provided by HUGIN

Filed Under: Facilities And Providers

Artificial Pancreas Improves Overnight Glucose Control for Range of Real-Life Situations, Latest Data Show

Posted on June 27, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

Researchers Also Identify Psychosocial Barriers to Use of CGM Devices; Symposium Provides Update on Advances That Could Lead to Rapid Commercial Development of an Artificial Pancreas System

ORLANDO, FL–(Marketwire – June 27, 2010) –  Research into whether an “artificial pancreas” can effectively control blood glucose levels in children and adults with type 1 diabetes continues to make rapid advances, leading those in the field to predict that technology could become commercially available within the next few years, according to speakers at a joint American Diabetes Association — Juvenile Diabetes Research Foundation (JDRF) symposium at the Association’s 70th Scientific Sessions®.

Results, presented for the first time at today’s symposium, show that adults with type 1 diabetes can use the artificial pancreas technology to significantly improve overnight blood glucose control without increasing the risk for hypoglycemia, across a range of real-life situations — even after eating a large meal and drinking a glass of white wine. Lead researcher Roman Hovorka, Ph.D, Principal Research Associate at the University of Cambridge Metabolic Research Laboratories, noted that such a system could greatly improve the lives of those who are insulin-dependent.

A second study, also presented for the first time at the Association’s 70th Scientific Sessions, helped to identify the psychosocial characteristics of people with type 1 diabetes most likely to successfully utilize continuous glucose monitoring (CGM) devices, an important component of an artificial pancreas system. This data, presented by Marilyn Ritholz, Ph.D, Senior Psychologist at the Joslin Diabetes Center and Assistant Professor at Harvard Medical School, should help physicians and other diabetes care providers to identify patients for whom the new devices are most likely to be beneficial.

Both studies are part of the JDRF’S Artificial Pancreas Project, a partnership that brings together diabetes researchers and businesses focused on making the artificial pancreas a reality. The American Diabetes Association joined forces with JDRF at its Scientific Sessions to promote the research behind this project and to raise awareness of efforts underway to improve the lives of people with diabetes who are insulin-dependent.

“This joint symposium highlights how major organizations working together can move these technologies forward,” said Richard Bergenstal, MD, Executive Director of the International Diabetes Center and American Diabetes Association’s President, Medicine & Science. “It’s going to require collaboration between many different organizations to come together to tackle this problem.”

“It’s very exciting to work together to help people with diabetes achieve their outcomes,” said Aaron Kowalski, Ph.D, Research Director of the Artificial Pancreas Project. “We’re all interested in people with diabetes achieving better glucose control. The community needs to hear what’s happening and where we are headed.”

The JDRF research involving artificial pancreas technology combines CGM with an insulin pump and a sophisticated computer program (called an algorithm) that can automate when and how much insulin to deliver. All but the computer program are technologies already commercially available to people with diabetes. Research trials performed so far within the JDRF Artificial Pancreas Project have tested various levels of automation, multiple computer programs, and a range of in-clinic situations, including large and small meals, nighttime control, and exercise.

However, “a fully automated system that administers insulin as needed during the night without human intervention is planned to be tested on children in their homes in the United Kingdom. Nobody has done such a study before,” Hovorka said.

“I think artificial pancreas systems are going to turn out to be among the most promising short-term clinical benefits of diabetes research,” said Richard Insel, Executive Vice President of Research at JDRF. “They are going to obviously allow individuals to more effectively manage their blood glucose levels, especially after eating, when exercising, and during the night while they sleep. Not only will that help prevent long-term complications of the disease, but low blood sugars will be prevented, and living with diabetes will be easier. Just preventing the swings in glucose levels will help. The benefits are countless.”

Partially Automated Systems in Development

Hovorka and his team from the University of Cambridge have completed several recent studies of the artificial pancreas that hold promise for both children and adults with type 1 diabetes. Earlier this year, The Lancet published their landmark study of children and teenagers with type 1 diabetes who experienced better control of blood glucose levels and lower incidence of hypoglycemia while sleeping, using a closed loop artificial pancreas system.

Today, during the joint American Diabetes Association-JDRF symposium, Hovorka outlined results of his most recent study, which showed these benefits remain consistent even after adults with type 1 eat a large meal and drink a glass of white wine before bedtime. The study found that using the artificial pancreas system, these adults spent 70 percent of their time within their target blood glucose range, up from 47 percent of the time they spend within target overnight without use of the artificial pancreas system. As in the other studies, time spent in hypoglycemia tended to be reduced, even though alcohol is known to increase the risk of nocturnal/next morning hypoglycemia for people with type 1 diabetes. Full results will be presented on Monday.

The Cambridge team has also begun preliminary research into how such a system might work for pregnant women with type 1 diabetes. Early results have examined overnight glucose control in this population to establish a baseline against which they can measure effectiveness using the closed loop artificial pancreas system. These preliminary results were discussed in a poster presentation here on Saturday.

Barriers to Continuous Glucose Monitoring (CGM)

A major component of the technology needed to produce an artificial pancreas is a continuous glucose monitoring (CGM) system, which relates blood glucose levels and the direction they are trending throughout the day and night, compared to the “snapshots” that are currently taken by pricking the skin and using test strips on a periodic basis. CGM involves inserting a glucose-sensing device called a “sensor” under the skin of the abdomen, where it takes a glucose reading from the tissue every few seconds and relays it to a handheld device or insulin pump.

“CGM has the potential to be one of the most important breakthroughs in diabetes management in many years, especially for type 1, probably since pump therapies were developed in the 1980s,” said William Tamborlane, MD, of Yale University, and co-chair of JDRF’s Continuous Glucose Monitoring Group. Holding back more wide scale adoption of the technology at present, he said, are technical imperfections that make the devices cumbersome to use and require frequent calibrations and manual confirmations to ensure accuracy. “What we have now are imperfect simulations of the perfect system,” he said. But the technology holds great promise because even while not yet perfected, research has shown that using it regularly can significantly reduce A1C levels without increasing severe hypoglycemia in those who used it as directed.

JDRF-funded studies have shown that adults over the age of 25 were able to reduce their A1C levels from 7.6 to 7.1, using CGM in conjunction with an insulin pump, he said. In children ages 8-14, A1C levels dropped from 8.0 to 7.6 using CGM. Teenagers did not see a benefit, but that is likely because they were less likely to comply with using the technology than the other two groups, Tamborlane said. Participants in the trials who used the technology regularly — more than six days per week — saw similar improvement regardless of age.

“To get a benefit from a device, you actually have to use it,” he said.

Most importantly, when using CGM, A1C levels were reduced half a percentage point without increasing the risk of severe hypoglycemia, Tamborlane said. Hypoglycemia is perhaps the biggest concern for people with diabetes looking to significantly lower blood glucose levels and can have serious negative consequences, such as loss of consciousness.

The Joslin Center’s Ritholz said her team studied the psycho-social barriers that can prevent people from successful use of a CGM system and found that those who used problem-solving skills for coping with frustration and anger; who saw CGM as a mechanism for better understanding glucose patterns; and who had good support from a spouse or significant other were most likely to achieve good results with using this technology. Conversely, those who had anger and impulse control issues, who failed to synthesize the data from CGM and who didn’t have good emotional support were less likely to benefit from CGM use.

Success was defined, in this study, as lowering A1C levels by at least half a percentage point (if levels were above 7 percent at baseline) or decreasing the amount of hypoglycemia (if levels were below 7 percent at baseline), Ritholz said.

“There needs to be attention paid to the people using CGM,” she said. “We can’t just focus on the technology. In determining individualized patient care, it’s important to pay attention to who is most likely to succeed with this technology. It’s not for everybody.”

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

About JDRF
JDRF is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump — each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. The goal of the JDRF Artificial Pancreas Project is to speed the development of automated diabetes management systems. Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.4 billion to diabetes research, including more than $100 million in 20 countries last year alone.

Symposium, Sunday June 27, 2 P.M.

Contact:

Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Facilities And Providers

Sunnybrook Health Sciences Centre: Emergency Medical Assistance Team Deployed for G8 Summit

Posted on June 26, 2010 Written by Annalyn Frame

TORONTO, ONTARIO–(Marketwire – June 26, 2010) – The Ministry of Health and Long-Term Care has deployed Ontario’s Emergency Medical Assistance Team (EMAT) to support capacity at the Huntsville District Memorial Hospital site of Muskoka Algonquin Healthcare. In anticipation of the many visitors expected in the region, the ministry has been working with the North Simcoe Muskoka Local Health Integration Network (LHIN) and local health service providers in the Simcoe-Muskoka region for over a year to develop plans to ensure there are minimal disruptions during the G8 summit.

The EMAT is funded by the ministry and is operated by the Sunnybrook-Osler Centre for Prehospital Care (SOCPC), a division of Sunnybrook Health Sciences Centre.

“The EMAT is providing additional critical care capacity in the region as part of a comprehensive health care plan to support the needs of this community”, said Robert Burgess, SOCPC Senior Director.

The EMAT mobile field hospital has been erected directly adjacent to the Huntsville District Memorial Hospital.

The Emergency Medical Assistance Team (EMAT)

Backgrounder

Q1. What is the Emergency Medical Assistance Team (EMAT)?

The EMAT is a part of the Ministry of Health and Long-Term Care’s (the ministry) health emergency response program and is an important component of Ontario’s overall emergency response capacity. The EMAT is funded by the ministry and is operated by Sunnybrook Health Sciences Centre. The EMAT is a 56-bed mobile field hospital that may be deployed by the ministry within 24-hours to any road-accessible community in Ontario. The unit provides the capacity to provide ongoing treatment for up to 20 acute care and 36 intermediate care patients and/or a staging and triage base for patients prior to transporting them to acute care hospitals and is medically self-sustainable (supplies, equipment, power, and personnel) for 72 hours.

Q2. What kind of health emergency response services does the EMAT provide?

The EMAT has the capacity to provide ongoing treatment for up to 20 acute care and 36 intermediate care patients and/or triage. The EMAT has expertise in: patient isolation in the case of an infectious disease outbreak; the provision of medical support and first receiver cold zone decontamination in the case of a chemical, biological, radiological or nuclear (CBRN) incidents; and assisting with managing patients in a mass casualty situation. If any jurisdiction in Ontario finds that it does not have the capacity to respond effectively to a health incident or emergency, the EMAT may be deployed to support the local health system.

Q3. How is the EMAT staffed?

The EMAT uses on-call professional health care providers from across the province who volunteer to work on the EMAT. Team members come from a variety of locations so that no single area is without vital health human resources at any given time. There are approximately 90 members including physicians, nurses, critical and advanced care paramedics and social workers, who are specially trained through the EMAT in health emergency management and response. Once the EMAT is activated, on-call volunteer workers are alerted and transported to the emergency site.

Q4. Who determines when the EMAT is deployed?

Deployment is based on an established set of criteria, including an immediate assessment of the local health care system’s ability to respond to the incident/ emergency, the availability of accommodations, water and food supplies for the EMAT volunteer workers, and an assessment of the emergency site (e.g., safety assessment for the mobile unit and EMAT volunteer workers). To deploy the EMAT, the local hospital and/or health system contacts the ministry with the initial request for EMAT support. If the situation meets the criteria, the ministry activates the EMAT.

Q5. How is the EMAT trained?

The EMAT team has the appropriate training and skills to function as a team in a health emergency environment involving infectious diseases outbreaks, natural disasters, CBRN, and mass causality incidents. The EMAT team trains regularly through full-scale exercises, which involve the participation of local health care organizations, and may also include local police, fire and ambulance services, as well as local municipalities.

Q6. What is the EMAT’s role at the G8?

The EMAT is a mobile field hospital that has been deployed to the G8 in Huntsville, ON to support capacity for the Huntsville hospital. It is onsite as part of the Ontario Ministry of Health and Long-Term Care’s work to ensure there is capacity for care for all patients.

Filed Under: Facilities And Providers

Bret Michaels Receives American Diabetes Association’s Chair’s Citation Award

Posted on June 25, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

Bret Michaels Presented With the Chair’s Citation Award Prior to World’s Largest Diabetes Meeting

ORLANDO, FL–(Marketwire – June 25, 2010) –  Bret Michaels, lead vocalist of Poison and winner of this season of “Celebrity Apprentice,” has received the American Diabetes Association’s prestigious Chair’s Citation Award in Orlando, FL. Bret will be the first recipient of the Award, which recognizes the outstanding accomplishments of individuals, corporations, institutions or organizations who have demonstrated significant dedication and commitment in their local market and have had a positive impact in advancing the mission of the American Diabetes Association.

“We are proud of Bret’s passion and commitment to raising funds for the American Diabetes Association. His efforts this year will truly help us change the future of this deadly disease,” said Larry Hausner, CEO, American Diabetes Association. “We are also very excited to continue our relationship with Bret and, together, help Stop DiabetesSM.”

Bret, who has type 1 diabetes, chose the American Diabetes Association as his charity during this season of “Celebrity Apprentice.” He raised $390,000 for the Association and has helped put a face to diabetes by raising critical awareness about the seriousness of diabetes and the importance of diabetes prevention and management.

The American Diabetes Association is the largest voluntary health organization committed to the fight to stop diabetes. Each year the Association honors volunteers who have made a significant contribution to this fight at its Community Volunteer Leadership Conference and National Board Meeting. Immediately following this conference, the Association hosts its Scientific Sessions with more than 13,000 top scientists, physicians and other health care professionals from around the world to share cutting edge research, treatment recommendations and advances toward a cure for diabetes.

Nearly 24 million children and adults in the United States have diabetes. Diabetes contributes to the deaths of more than 230,000 Americans each year. The American Diabetes Association estimates that the total cost of diagnosed diabetes in the United States is more than $174 billion; further published studies suggest that when additional costs for gestational diabetes, pre-diabetes and undiagnosed diabetes are included, the total diabetes-related costs in the United States could exceed $218 billion. 

About Bret Michaels
Bret Michaels, lead vocalist of Poison and winner of this season’s “Celebrity Apprentice,” has an album coming out on July 6, 2010 called “Custom Built.” Bret will also be producing and appearing in a new reality show on VH1 called “Bret Michaels: Life as You Know It.”

About the American Diabetes Association
The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Angela Murray
800-676-4065 ext. 3425
[email protected]

id=”nav_links”>

Filed Under: Facilities And Providers

Choosing To Switch To A Paperless Medical Practice

Posted on June 9, 2010 Written by Annalyn Frame

Most medical practices now use an electronic practice management (EPM) system. Usually this means some type of proprietary software, something different than the old system of hand-written calendar notes. In the last twenty years, the EPM market has ballooned into a large industry, generating products which run on several platforms.

Unfortunately, however, although these systems are enacted, the vision of the paperless office is not fulfilled. Most practices still store paper records in the old-fashioned way. Some practices are text-driven, such as family practices and internal medicine. Graphical and visually-driven specializations like ophthalmology, however, have given developers trouble and many systems are not ready to go live.

At our practice we had been using an EPM system since ’83. The first vendor we were using said that they would not extend technical support after the year 2000. We decided to change to another system before this happened. While the software was good for billing and scheduling, we started to realize that we would need to keep growing in terms of square footage, in order to accommodate the storage of medical records. So, we asked ourselves which would be more cost-efficient in the end: conversion to an EMR system, or continual growing of the space? Our particular practice has five office spaces with records storage at the central main office. We started to consider a scanning solution to assist with the storage problem, still realizing that we’d have to become more efficient while maintaining full access to stored information.

EMR system implementation involves the following expenses:

* technical support
* IT consulting
* infrastructure costs
* computer hardware
* licensed software

Also consider the costs of training staff, and the extra data entry that they will perform to move information over to the new system. In most cases, a practice will use both the new and old systems until a conversion is complete. There could be some tasks duplicated between the two systems.

Our choice came down to a consideration of the necessity to curb the amount of paper records we were accumulating, meanwhile facing new privacy and patient record security proactively.

There are some excellent benefits to EMR, which include:

* enhanced documentation
* remote access
* improved coding and compliance
* better integration
* communication improvements
* measured efficiency

When making our choice, we imagined that we could recover our investment in five years; this calculation was based on savings on estimated office space rental needs. This includes reduced service costs and printing expenses. We are monitoring changes in job efficiency. There are benefits which are difficult to calculate accurately, but we are always measuring our performance and return on investment. There will be an initial investment of both time in expense which should reap benefits in terms of future productivity.

The overall trend seems to look toward a future in which EMR is the standard rule. Insurance providers and government agencies are increasing pressure for standardized medical documentation, and EMR could become obligatory someday. As healthy competition brings down hardware and software costs, even the smaller offices are then able to make the move over to a paperless practice.

Filed Under: Healthcare Plan News

Laser Eye Surgery Belfast Clinics

Posted on June 5, 2010 Written by Annalyn Frame

If your at the stage where you feel you no longer feel like wear glasses – whether you only use them for driving at night or reading or daily use or or if you want a break from the hassle of constantly changing contact lenses you can go for laser eye surgery Belfast clinics which can improve your vision. Laser eye clinics in this part of the world seem to be 10 a penny. You should carry out some research on the clinics offering the surgery here if you are going to be using them. The most important point and it makes no difference the location, is to only use experienced and qualified surgeons with a strong history of previous successful operations .

If you therefore think Belfast laser eye surgery is for you you’ll learn more details if you book a consultation at one or a number of practises. Then if you decide you want to pursue with the operation you will clinic will perform an eye test to work out your levels of your eyesight in very high detail. Most peoples eyes are completely unique and the difference between the vision of our own eyes can also be totally different .

Once the complicated optometrist eye scanning test has been carried out you could be required to sit through some more tests such as the state of the art Artemis™ corneal scanner test. There are a host of surgery options such as LASIK, PRK and LASEK available to you in Belfast . Your type of surgery will be dictated to your eye conditions and the limitations of your budget. There is a whole host of other techniques from lense implants, cross linking and artificial lenses. An experienced eye surgeon can recommend the best treatment options for your eye conditions .

Lots of folks have been rejected for laser eye surgery by some eye surgeons in Belfast before as it was thought the person or even the surgeons could not perform successful laser eye surgery. Something commonly stated for rejection was that the patient was too old , or rather their eyes had preamaturely aged this is known as presbyopia), and nothing could be done to benefit their deteriorating eyesight. With the pace and advancement of medical break throughs new techniques have been put to trial that have had exceptional advances for laser eye surgery. One such technique called Laser Blended Vision Surgery has had great results in improving the eyesight where presbyopia had set in .

There is a massive market for laser eye surgery Belfast clinics servicing the 30 and over age bracket . This is more true than ever as we progress into an an aging society were most of us are living longer because of diet and health changes . It is noticeable many people who used to have good eyesight in their youth notice that by the time they get to their forties their eyesight becomes weaker . Its a good job most of the small visual incorrections can be fixed with laser eye surgery.

Some of the pitfalls of laser eye surgery are you can have poor vision during night and experiencing halos around bright lights. You may also suffer dryness in the eyes. Remember as with most surgical procedures there are associated complications, a good surgeon will be able to explain all the risks of laser eye surgery.

Filed Under: Healthcare Plan News

Health Insurance policy

Posted on May 4, 2010 Written by Annalyn Frame

Getting Health Insurance Quotes By Phone
Though calling around for insurance quotes will be a terribly time-consuming task, it is a sensible approach to get your questions answered about the policy by a professional. In several cases, calling an insurance company for a quote will result in an automated session and then being placed on hold. This can be the kind of frustration that you’ll face, time and again, when making an attempt to receive any quite insurance quote by phone.

It will take up a heap of time and you are doing have to stay notes about every quote you receive, but there are some good reasons for getting health insurance quotes by phone:

• You’ll be able to speak to a skilled in real time
Eventually, you will get through to an actual person on the opposite finish of the phone. This person can explain the policy to you in detail, answering any queries you may have as they come up.

• You’ll be able to learn about different premiums and choices on the same policy
When a bound health insurance policy interests you, you will be ready to talk to somebody concerning adjusting the premium and/or deductible on the policy, tailoring it to raised fit your needs.

• You can purchase a policy immediately
By using a check by phone or your credit card, you can purchase a policy based on the health insurance quotes you receive over the phone. This process is mostly fast, as well as a brief question-and-answer session.

Obtaining Health Insurance Quotes On-line
For those who prefer a quick and straightforward method of insurance looking, the Web is certainly your best option. Using the Web, you’ll be able to head to a selected company’s web site and learn additional about their policies by receiving free on-line health insurance quotes, or compare and distinction the policies offered by several corporations at once.

The Web allows you to receive several more health insurance quotes, in an exceedingly much shorter amount of your time than you would be receiving quotes over the phone. There are a number of advantages to shopping for health insurance quotes online:

• You can get several health insurance quotes, fast
When time could be a factor, the Net is your best friend. You’ll be able to examine many totally different health insurance quotes at the identical time on-line, a lot of additional quickly than it takes to get through most phone automated systems.

• You can compare tons of health insurance quotes directly
Aspect-by- aspect or page-by-page, with the Net you’ll compare health insurance quotes from several totally different health insurance companies at once. This makes comparison shopping a breeze.

• Simple purchase
You’ll usually purchase a health insurance policy online, employing a secured method and your credit card. This allows you to get your health insurance policy quickly, therefore that coverage will start right away.

An Independent Agent
When doing your own research, finding completely different quotes, calling around or even using the Net to buy just isn’t your thing, you’ll wish to use an independent insurance agent. These agents don’t work for any specific company except for you. They use their time to shop around for you, finding you the most effective potential policy based mostly upon the health insurance quotes they receive.

Typically, freelance agents will get much higher rates than the common customer. This is as a result of insurance company provide agents deals and discounts merely for brining in new business. An freelance agent will work for you to find the most effective health insurance quotes, thus that you simply pay less while still receiving the best coverage doable for you and your family.

Filed Under: Healthcare Plan News

American Medical Association AMA Foundation Seed Grant Research Recipients

Posted on March 18, 2010 Written by Annalyn Frame

The American Medical Association (AMA) Foundation has awarded medical research grants to 38 junior investigators. Established in 2000, the Seed Grant Research Program provides medical students, physician residents and fellows with grants of up to $2,500 to conduct basic science or clinical research projects.

ama-foundation

This year’s recipients are studying cardiovascular/pulmonary diseases, HIV/AIDS, leukemia, and neoplastic diseases.

The 2010 recipients are:
— Christopher Alvarez-Breckenridge, Ohio State University College of Medicine
— Hans Arora, Northwestern University
— Deanna Cettomai, MHS, Johns Hopkins University School of Medicine
— Akash Chandawarkar, Harvard Medical School
— Kevin Chen, Duke University School of Medicine
— David Clifton, University of Texas Medical Branch
— Jeffrey Costas, MS, Arizona College of Osteopathic Medicine at Midwestern University
— Andrea Dean, Yale University School of Medicine
— Dustin Deming, M.D., University of Wisconsin School of Medicine and Public Health
— Kelsey Derricks, Boston University School of Medicine
— Laura DiNardo, University of Pennsylvania School of Medicine
— Darshan Doshi, M.D., Columbia University College of Physicians and Surgeons
— Caitlin Elgarten, Columbia University College of Physicians and Surgeons
— Curtis Gabriel, Vanderbilt University School of Medicine
— Ann-Johanna Giaccone, M.D., Children’s Hospital of Philadelphia
— Allen Ho, Harvard Medical School
— Anna Kamp, M.D., MPH, University of Michigan Medical School
— Nicolas Kummer, New York Medical College
— James Lester, Edward Via Virginia College of Osteopathic Medicine
— Rung-chi Li, Ph.D., Touro University College of Osteopathic Medicine
— Ta-Chiang Liu, M.D., Ph.D., Washington University in St. Louis School of Medicine
— Su Luo, Massachusetts General Hospital
— Joshua Meisner, MS, University of Virginia School of Medicine
— Benjamin Nacev, Johns Hopkins University School of Medicine
— Michael Nguyen, MS, Saint Louis University School of Medicine
— Toral Patel, M.D., Yale University School of Medicine
— Jarrod Predina, University of Pennsylvania School of Medicine
— Greg Rice, Kansas City University of Medicine and Biosciences
— Shreyas Roy, M.D., CM, SUNY Upstate Medical University
— Lynn Rudner, University of Utah School of Medicine
— Sarah Russell, Keck School of Medicine of the University of Southern California
— Hersh Sagreiya, Stanford University School of Medicine
— Shiraj Sen, University of Texas Medical School at Houston
— Keri Seymour, DO, SUNY Upstate Medical University
— Natalie Shaw, M.D., Massachusetts General Hospital
— Preeti Sukerkar, Northwestern University
— Jesse Sulzer, Louisiana State University Medical Center
— Rabi Upadhyay, University of Massachusetts Medical School

The Seed Grant Research Program was created to encourage more physicians to consider research as a career option. Many recipients go on to publish their work, present at scientific meetings, or even secure larger grants.

The AMA Foundation supports a broad range of programs in public health and medical education. Visit www.amafoundation.org to learn more.

Source: American Medical Association Foundation

Filed Under: Healthcare Plan News

Fake Prescriptions Still an Issue; Corey Haim Death Highlights Problem

Posted on March 13, 2010 Written by Annalyn Frame

With the recent untimely death of actor Cory Haim this week, the public is learning about an industry-wide problem that continues to plague the health insurance industry, fake prescriptions.

corey-haim

Corey Ian Haim (December 23, 1971 – March 10, 2010) was a Canadian actor, best for his 1980s Hollywood career as a teen idol. Mr. Haim starred or co-starred in a number of movies like Lucas, Murphy’s Romance, The Lost Boys, License to Drive, and Dream a Little Dream. Corey Haim appeard many times alongside his friend Corey Feldman. The two later starred in the hit A&E reality television show called The Two Coreys.

Corey Haim died an untimely death on March 10, 2010.

According to the Examiner, “A state investigation turned up an unauthorized prescription in Corey Haim’s name. According to People.com, the illegal prescription was noticed when investigators ordered drug pads from a San Diego vendor. The prescriptions were filled out by using the stolen identity of doctors. Authorities have described this prescription drug ring as “massive”.

California Attorney General Jerry Brown said that the illegal prescription made out to Corey Haim was for the pain killer OxyContin. The prescription was located through the California computer database that tracks all prescriptions that are filled in the state.”

The Associated Press is also reporting that “California Attorney General Jerry Brown said records of the prescription in the name of the former teen heartthrob were found during an investigation of the ring that illegally obtained prescription pads and used the stolen identities of doctors to fill them out.”

The public is learning of the problem of fake drug prescriptions because of this celebrity’s untimely death and the fact that one of the prescriptions that was part of illegally obtained prescription pads and the stolen identities of physicians. There continues to be calls for changes in the way prescriptions are written that will make it more difficult for fake prescriptions to be obtained by the public.

Filed Under: Healthcare Plan News

TriCipher myOneLogin SignatureBook Offers Digital Signatures On-Demand

Posted on February 28, 2010 Written by Annalyn Frame

TriCipher, a leading provider of Internet identity services, today announced a hosted, on-demand version of its powerful digital signature solution. myOneLogin SignatureBook is an on-demand service that accelerates and streamlines business processes requiring non-repudiable signatures across different groups, organizations or geographic locations. It supports a number of different online credentials, including a clientless credential and the SAFE-BioPharma digital signature widely adopted in healthcare and pharmaceutical industries.

“The SAFE-BioPharma® signature standard provides a high level of trust assurance for digital identities, and is instrumental to speeding processes and reducing costs in the healthcare and pharmaceutical industries,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. “The Tricipher myOneLogin SignatureBook service offers SAFE-BioPharma members a means of improving business process and simplifying the signing process. This service will be especially attractive to the growing body of smaller companies which have joined SAFE-BioPharma as a step toward improving their workflows and converting to paperless operations.”

myOneLogin SignatureBook collects digital signatures on an electronic document, automatically applying signature policies and streamlining processes of collecting and validating signatures. It creates an original, signed version of a final document as well as a flattened PDF without active signature blocks, suitable for distribution. As an on-demand service, myOneLogin SignatureBook is easy to deploy, and is particularly useful for organizations with many business processes requiring signatures by multiple parties. The service offers several different signature methods, including a TriCipher clientless credential and with credentials compliant with the SAFEBioPharma digital signature standard. myOneLogin SignatureBook is the in-the-cloud, hosted version of the on-premise TriCipher mySignatureBook digital signing solution.

“Digital signatures are a natural extension of the Internet identity services that we provide at TriCipher, making it easier and more secure to do business on the web,” said John De Santis, chairman and CEO at TriCipher. “The on-premise TriCipher mySignatureBook solution is already adopted in large pharmaceutical organizations. By offering these capabilities as an on-demand service, we deliver on the promise of digital signatures for a wider range of businesses.”

For more information, please visit www.myOneLogin.com.

Filed Under: Healthcare Plan News

15 Ways to Take Care of Your Elderly Parents

Posted on August 2, 2009 Written by Annalyn Frame

US News and World Report Health has a great article about caring for elderly parents. They say that there are fifteen ways:

“The first step toward avoiding such baptism by fire is to acknowledge you’ll most likely take on caregiving responsibilities someday. According to the Family Caregiver Alliance, the number of “unpaid family caregivers” is set to reach 37 million by 2050, an 85 percent increase from the year 2000. You can help your parents stay happily independent as long as possible if you start those tough conversations now and do some thorough preparation. Here’s a game plan.”

15 Ways to Take Care of Your Elderly Parents:
1-5: Preparing the Home
6-8: Safeguarding Their Health and Safety
9-12: Protecting Their Finances
13-15: Keeping Them Socially Connected

1. Consider hiring a pro

2. Keep track with technology. Helping your parents remain in their home may be realistic but typically requires at least a few adjustments to keep them comfortable and safe.

3. Remove booby traps. The National Association of Home Builders has certified aging-in-place specialists who can consult and make structural changes.

4. Visit frequently. The time together matters, plus you’ll have a better sense of whether they’re safe, mentally sound, and in the best living situation, says Alexis Abramson, author of The Caregiver’s Survival Handbook.

5. Anticipate expenses

6. Work with the pharmacy. “Poor medication management is the No. 1 reason for leaving an independent living situation and going into supervised care,” says Elinor Ginzler, coauthor of Caring for Your Parents: The Complete AARP Guide.

7. Get help behind the wheel. One of the messiest challenges for adult children and their parents to navigate is the driving question..

8. Draw up the documents.

Filed Under: Healthcare Plan News

New Study Shows Uninsured Crisis Wildly Overestimated

Posted on June 23, 2009 Written by Annalyn Frame

The Employment Policies Institute (EPI) has released the results of a new study. that shows that the “widely employed estimate of 47 million uninsured Americans is a misleading representation of the problem.”

The study, authored by Drs. June and David O’Neill of Baruch College and City University of New York, shows that more than 43 percent of uninsured Americans ages 18-64 could likely afford health coverage and are actually “voluntarily uninsured.”

Using data from a number of surveys to determine what percentage of uninsured Americans are actually unable to afford it, the study finds that at least 43 percent of Americans in the 18-64 year-old age group have incomes at least 2.5 times the poverty level and are “voluntarily” uninsured.

The study finds that 79 percent of people with incomes between 2.5 and 3.75 times the poverty level currently purchase private health insurance. In view of the large percentages covered at this level, the authors consider this uninsured group as having enough disposable income to purchase health insurance.

The uninsured population also varies dramatically from state to state. For example, thirty percent of Texas residents are uninsured, compared to 18 percent of New York and 13 percent of D.C. residents. Three states (Texas, Florida and California) make up a third of the uninsured population.

Filed Under: Healthcare Plan News

US Healthcare System Prepared for Swine Flu

Posted on April 27, 2009 Written by Annalyn Frame

The entire healthcare system in the United States is prepared for the Swine Flu if it becomes a national epidemic. Many organizations are working with the CDC in order to keep updated on the latest information about this influenza virus.

IBHS Cautions Businesses to Prepare for Flu Pandemic; Provides Free Self-Assessment Tool to Rate Readiness
The Institute for Business & Home Safety (IBHS) is cautioning businesses and nonprofit organizations to examine their ability to operate in the event of a flu pandemic.

With the federal government declaring Swine Flu a public-health emergency, IBHS says it would be wise to prepare now for the possibility of closures or other impacts a pandemic could have on operations.

“Evaluating specific risks and planning well beforehand for a variety of potential emergencies that could disrupt day-to-day business is critical, no matter how big or small a company may be,” states IBHS President and CEO Julie Rochman. “Fortunately, most catastrophes can be managed with advance, effective preparation – and that means having a well-thought out action plan with specific, appropriate policies, resources and contingencies.”

The Top 5 IBHS pandemic preparedness steps include:

1. Determine when to curtail employee travel, domestically and
internationally.
2. Develop business continuity policies that provide work-at-home options.
3. Address sick leave policies, since people with swine flu or those
attending to relatives may need to be on leave longer that the current
policy allows.
4. Consider the impact a shutdown of public transportation or the loss of
basic utilities would have.
5. Determine at what point the organization would need to close its doors.

IBHS has created a self-assessment tool for business owners and managers who can rate their readiness for a flu pandemic by answering nine basic questions. http://www.disastersafety.org/resource/resmgr/pdfs/pandemic_flu.pdf

Trust for America’s Health Applauds U.S. Response to Swine Flu
Trust for America’s Health (TFAH) today commended the Administration for its fast and effective response to the swine flu outbreak.

In order to continue to respond to this swine flu outbreak and to continue and improve preparations and the capacity to respond to other potential pandemic outbreaks, such as the H5N1 “bird flu,” TFAH recommends:

— Completing the funding to implement the National Strategy for Pandemic
Influenza. Former President Bush originally requested $7.1 billion to
carry out research and development for vaccinations, pharmaceuticals,
and medical devices needed to respond to a pandemic. $870 million of
this has never been funded. This funding was originally included in
both the FY 2008 budget and proposed 2009 stimulus bill, but was
removed each time before the bills’ final passage.
— With more than $1 billion of HHS funding, six companies are in various
stages of implementing commercial-scale production of cell-based
methods and/or expanding their vaccine capacity using eggs. By 2011,
U.S. based vaccine production capacity is expected to be at a point in
which it can generate enough pandemic influenza vaccine for every
American within six months of the time that the pandemic virus is
identified, according to the most recent Pandemic Planning Update from
HHS. However, the U.S. will not reach that capacity without completion
of the initial investment.
— Replenishing and building the Strategic National Stockpile. Purchasing
antiviral medications, vaccines, and equipment for the stockpile
should be a federal responsibility. Responding to this outbreak will
require using a significant portion of the currently stockpiled
Tamiflu(R) and other medical equipment, such as respirator masks.
These medications and equipment will need to be restocked. In
addition, the stockpile has existing shortfalls in the number of
masks, respirators, and medications needed to respond to this and
other possible pandemics, which must be completed to be prepared for
the possibility of other strains of flu.
— At the end of 2008, the Strategic National Stockpile reportedly
contained 104 million N95 respirators; 51.6 million surgical masks; 20
million syringes for pre-pandemic vaccine; 4,000 ventilators.
— Purchasing antiviral medications should become solely a federal
responsibility. Under the plan from the previous Administration,
states were expected to purchase a portion of the antiviral
medications that would be needed to protect citizens in their
states, through a program that included 25 percent subsidy from
the federal government. While the federal government has purchased
enough antivirals to cover 50 million Americans, as of October
2008, states only had purchased 22 million courses of antivirals,
which is nine million short of the goal, leaving Americans in some
states more vulnerable than others.
— Providing resources for state and local health departments to
adequately prepare for outbreaks. State and local officials are the
front line responders to outbreaks, yet they have not received any
federal funding for pandemic flu preparedness since FY 2006. $350
million is needed annually to adequately maintain state and local
pandemic preparedness activities.
— All 50 states and D.C. have a pandemic flu preparedness plan.
— All 50 states and D.C. have adequate plans to receive and
distribute emergency vaccines, antidotes, pharmaceuticals, and
medical supplies from the SNS, based on a review by CDC.
— All 50 states and D.C. have increased or maintained rates for
vaccinating adults ages 65 and older for seasonal flu, which is a
key indicator for showing how well states could vaccinate
individuals in an emergency.
— All but three states reported that their public health
laboratories meet the expectations of their state’s pandemic flu
plan (as of November 2008).

— Increase support for the Global Disease Detection (GDD) program. In
2007, the GDD program received $33.7 million in funding. If the
funding was increased to $55 million, four additional regional
detection centers could be established to improve global disease
outbreak detection and control.

Some additional ongoing challenges for pandemic preparedness that TFAH has identified in recent analyses include:

— Maintaining real-time disease detection and surveillance capabilities;
— Managing mass casualty care if there is a major surge in patients at
hospitals and treatment facilities;
— Ensuring the ability to swiftly and safely distribute and administer
medical treatments and vaccines;
— Reaching and providing special services for at-risk and vulnerable
populations, including children, the elderly, and low-income
communities;
— Bolstering the public health workforce with enough experts and
officials, many state and local health departments have experienced
workforce cuts during the recession; and

— Protecting health officials and volunteer medical providers during
emergencies.

TFAH’s annual health emergency preparedness report, Ready or Not? Protecting the Public’s Health from Diseases, Disasters, and Bioterrorism, and a report that examined the potential impact of a severe pandemic outbreak, Pandemic Flu and the Potential for U.S. Economic Recession, are available on TFAH’s Web site: www.healthyamericans.org. Also, brochures about how individuals, businesses, community-based organizations and the medical community are available at the Web site.

Trust for America’s Health is a non-profit, non-partisan organization dedicated to saving lives by protecting the health of every community and working to make disease prevention a national priority.

Travellers to Mexico so far Undeterred by Swine Flu Outbreak
Data from leading flight search company Skyscanner (http://www.Skyscanner.net) shows that travellers planning trips to Mexico have so far been undeterred by the outbreak of swine flu influenza announced by Mexico’s Federal Health Ministry on the 22nd April.

“Dire predictions have already been made about the impact that this will have on tourism, but the number of Skyscanner users searching for flights to Mexico has remained stable in the days since news emerged of the outbreak,” said Skyscanner director and co-founder Barry Smith.

“We would have expected to see some negative impact by now, but it may be that travellers are reassured by the fact that the outbreak is largely concentrated in Mexico City – a two hour flight from the coastal resorts – and by the fact that the Foreign Office, World Health Organisation and the US Center for Disease Control and Prevention have not yet made recommendations that people stay away. We’ll get a clearer picture in the next few days as the news spreads and the implications for travellers are fully understood.”

Skyscanner is the most powerful and flexible flight search engine in Europe, providing instant online comparison on flight prices for over 670,000 routes on over 600 airlines. With Skyscanner, users can browse without having to enter specific dates or even destinations, and Skyscanner is available in 20 different languages including French, German and Spanish.

Swine Flu: Infection Control in Hospitals Will Be Critical
In response to confirmed cases of swine flu in Mexico, Canada, and the United States, European Union health officials are advising against travel to North America. At airports in Japan and several other Asian countries, thermal scanners are being used to identify fever among passengers from North America.

But in the U.S. the disease is already among us. The severity and extent are unknown. The SARS outbreak (severe acute respiratory syndrome) in 2003 teaches that rigorous infection control in hospitals may be key to limiting deaths from swine flu in the U.S. Much will depend on what hospitals do when the first seriously ill victims arrive.” If hospitals have effective infection controls in place, the disease can be prevented from spreading to visitors, healthcare workers and their families,” warns Betsy McCaughey, Ph.D., and Chairman of the Committee to Reduce Infection Deaths (RID), a national organization that educates the public and medical community about preventing infection. McCaughey explains that “77% of the people who contracted SARS in the Canadian outbreak were patients, visitors or workers in hospitals. SARS was almost entirely a hospital infection epidemic.”

SARS — four letters that filled the headlines in the spring of 2003, and then disappeared. “A report issued after the fact by the government of Ontario (The SARS Commission, Spring of Fear, December 2006) shows how hospitals in one city thwarted an epidemic while hospitals in another city made deadly mistakes” says McCaughey, an expert on preventing infection.

Many hospitals in the U.S. are under-prepared for a similar challenge. As many as ten percent of patients contract infections in the hospital, according to the Centers for Disease Control and Prevention. Bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and Clostridium difficile race through hospitals, spread by unwashed hands and unclean equipment. How can hospitals that are failing to prevent ordinary infections spread by touch contain a new, unknown virus that can spread whenever someone coughs or sneezes?

“The best defense against swine flu and other unknown pathogens is rigorous hospital hygiene and routine infection prevention. That is the lesson of SARS,” says McCaughey.

Dr. McCaughey is available to speak about the precautions that should be taken in hospitals, schools, day care centers, nursing homes and other places where the disease can spread easily.

Betsy McCaughey, Ph.D., is founder of the Committee to Reduce Infection Deaths and former Lt. Governor of New York State.

http://www.hospitalinfection.org/

Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu
The Commonwealth of Pennsylvania is working with federal officials to contain the impact of an outbreak of swine flu in Mexico that resulted in the declaration of a national public health emergency in the United States.

The Department of Health is working to educate the public and health care providers of recommended steps to prepare for potential cases of swine influenza in Pennsylvania.

The Department of Health has notified health care providers across Pennsylvania to be watchful for patients with influenza-like illness who may have been exposed to the new swine flu strain and to immediately inform the local health department of any suspected cases. The department will assist all health care providers in evaluating the patients, recommending control measures, and assisting in specimen collection and testing when indicated.

This notification follows confirmation of a new strain of swine influenza A/H1N1 virus in Mexico and five locations in the U.S., including New York and Ohio. To date, all U.S. cases were “mild” with only one person requiring brief hospitalization.

According to the U.S. Centers for Disease Control and Prevention, swine influenza A/H1N1 is a new strain of influenza that has not previously been detected in swine or humans. The virus has also been confirmed in Canada and Mexico. It is still safe to eat pork and pork products.

The Department of Health provided information to all of the state’s health care providers and hospitals late Friday regarding the swine flu, including how to quickly report possible cases and how to submit samples for testing. Anyone who has traveled to or from the affected areas and has a respiratory illness should contact their health care provider or local health department before seeking health care.

Swine influenza is a respiratory disease of pigs caused by type A influenza viruses. Outbreaks of swine flu happen regularly in pigs. Before the current outbreak, people rarely got swine flu, and usually only if they were in very close proximity to infected pigs. However, during the current outbreak, the virus is able to spread from person-to-person.

Symptoms of swine flu in people are similar to those of regular or seasonal flu and include fever, lethargy, lack of appetite and coughing. Some with swine flu also have reported runny nose, sore throat, nausea, vomiting and diarrhea. Although winter is over, there is still a low level of seasonal influenza occurring in the state.

There is no vaccine available at this time, but the swine flu can be treated with certain antiviral drugs. Persons with swine flu are contagious for up to seven days or longer after the onset of illness, so it is important to take the following steps to prevent spreading the virus to others:

— Stay home when you are sick to avoid spreading illness to others;
— Cough or sneeze into the bend of your elbow or a tissue and properly
dispose of used tissues;
— Wash your hands frequently and thoroughly with soap and warm water or
use an alcohol-based hand sanitizer;
— Avoid touching your eyes, nose and mouth;
— Stay healthy by eating a balanced diet, drinking plenty of water and
getting plenty of rest and exercise; and
— Seek care if you have influenza-like illness.

The CDC is asking that those individuals who have a recent history of travel and experience mild, flu-like symptoms to stay home. However, if you feel your symptoms worsen or become severe, call or visit your health care provider.

For more information on Swine Influenza A/H1N1, contact the Department of Health at 1-877-PA-HEALTH or visit www.health.state.pa.us.

Filed Under: Healthcare Plan News

New CenterWatch Report Examines Japan’s Surging Clinical Trials Market

Posted on April 1, 2009 Written by Annalyn Frame

In 2007, drug development in Japan, the world’s second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today.

Japan: Opening the Door to Global Clinical Trials, the fourth in a series of CenterWatch reports on global clinical research markets, takes a look at the reasons for Japan’s dramatic growth, the differences in the country’s approach to clinical research, and government initiatives to attract Big Pharma to conduct simultaneous global clinical trials in Japan.

“New government initiatives have helped to streamline drug review and approval processes, and sponsor companies have responded by including Japan in their global drug development programs more,” said Sara Gambrill, senior editor at CenterWatch and author of the report. “Japan is participating in global drug development at historic levels; however, there is still work to be done there to sustain that growth.”

This is an essential resource for any business seeking to better understand Japan’s clinical trials landscape and what to expect when conducting clinical research there.
– See more at: http://www.centerwatch.com/news-online/article/33/new-centerwatch-report-examines-japans-surging-clinical-trials-market#sthash.iXq1pwgG.dpuf

Filed Under: Healthcare Plan News

New CSC Survey Predicts Continued Decline in Health Plan Enrollment

Posted on December 17, 2008 Written by Annalyn Frame

According to a survey released today by CSC (NYSE:CSC), entitled “Insuring the Future: Health Plans Respond to the Financial Crisis”, about 75 percent of health plan executives expect the current economic crisis to have a greater impact on their business than the 2001-2002 economic downturn.

While few of the health plan executives surveyed expect immediate changes in enrollment and membership levels in health plans, more than two-thirds expressed concern that continued rising unemployment would drastically affect their plan operations and profitability.

54 percent of health plan executives expect small group health plan and business health plan renewals to decrease. Large employers are expected to maintain their commitment to group health insurance coverage. Less than 31 percent expect a decrease in large group health plan renewals. However, almost three-quarters of plan executives foresee an increase in consumer-directed plans with higher deductibles and lower premiums as employers shift more of the cost to their employees. Nearly two-thirds expect an increase in government program enrollment as economic disruption and unemployment expand welfare participation.

The survey research was conducted in November of 2008. CSC interviewed 30 senior health plan executives that represented 26 different health plans. 83 percent of the participants hold C-level positions. To view the results report, visit go here.

CSC’s Global Health Care sector, which serves health care providers, health plans, pharmaceutical and medical device manufacturers, and allied industries around the world, is a global leader in transforming the healthcare industry through the effective use of information to improve health care outcomes, decision-making and operating efficiency.

Filed Under: Healthcare Plan News

Medical Tourism: World-class Medical Care at Affordable Rates

Posted on December 9, 2008 Written by Annalyn Frame

The US healthcare system is the best in the world! — Only if you can access and afford it. According to the World Health Organization (WHO), a good healthcare system should ideally comprise of state of art medical facilities being fairly distributed across the entire population at fair and affordable rates. Contrary to this, the healthcare system in the United States is not only the most expensive in the world but also is unfairly distributed among its population. People who have access to an insurance cover may have some respite, but the scenario is hopeless for the poor, uninsured and the underinsured. The rising costs of technology and high administrative costs have escalated the overall medical expenses to such an extent that it has become too expensive for the people at large. On the other hand, the availability of similar medical facilities at fair rates in some of the offshore countries has made them a promising medical destination for the US citizens. This has led to the emergence of a phenomenon called medical tourism.

The recent years has seen an upsurge in the number of US citizens opting for medical treatment at offshore locations such as India, Singapore, Bangkok and Thailand. Most medical procedures in these countries are conducted at one-tenth of the cost of a similar procedure at the United States. The low cost of medical facilities in these countries may raise a few eyebrows regarding the quality of the medical services being offered. These countries offer world-class medical facilities that are at par with the best. Some of the doctors administering the patients have even been trained in US. The success rate and medical achievements has also been a major draw among the medical tourists. In the year 2005, around 3,74,000 medical tourists opted for a treatment at Singapore; a Bangkok hospital admitted over 1,50,000 foreign patients and approximately 1,00,000 tourists chose India as their medical destination.

However, among the various medical tourism destinations, India is on it’s way to becoming the most preferred destination among the medical tourists. The Indian healthcare industry with employee strength of over four million is among the largest service sectors in the economy. The government and the private hospitals are working together towards the objective of making India the leader in this sector. Well-trained and experienced doctors, state of art medical facilities and personalized care have helped India to register the fastest growth rate in this Industry. The number of patients seeking treatment in India has gone up from 10,000 in the year 2000 to 100,000 in the year 2005. If the estimates are to be believed, the medical tourism industry in India has the potential to be a 2 billion dollar industry by the year 2012.

Medical tourism is the best alternative for people belonging to countries such as the United States, where the entire healthcare system is unfair both in terms of cost and accessibility. The situation has become so precarious that it seems beyond repair. However, on the other side of the Pacific, the Asian countries have succeeded in offering a combination of world-class medical services, good care and prompt attention that has made them an instant favorite among patients throughout the world.

Filed Under: Healthcare Plan News

150th Cyberknife System Installed Worldwide

Posted on December 8, 2008 Written by Annalyn Frame

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, recently announced that 150 CyberKnife® Robotic Radiosurgery Systems now have been installed worldwide. This milestone was achieved when Hospital Corporation of America (HCA), a leading healthcare services company, installed a CyberKnife System in collaboration with consultant clinician partners at The Harley Street Clinic in London. HCA’s addition of this CyberKnife System marks the installation of its seventh system companywide, including its first outside the United States.

“The combination of the CyberKnife Systems’ robotic mobility and integrated imaging system provides us with a powerful tool for treating tumors with a precision that wasn’t possible before,” said Nick Plowman, M.D., oncologist and clinical director of The CyberKnife Centre London. “The CyberKnife System not only improves the accuracy with which we can target tumors, but provides the patient with a pain-free experience that minimizes side effects and shortens treatment time.”

Availability of the CyberKnife System has grown dramatically, increasing by 50 percent since May 2007 when the company announced that the 100th CyberKnife System was installed at Centre Oscar Lambret in Lille, France. Additionally, patient demand for CyberKnife radiosurgery is on the rise with the number of patients treated increasing more than 34 percent during fiscal year 2008. Prostate and lung radiosurgery seem to be driving the demand, having grown approximately 95 percent and 44 percent respectively during the last fiscal year.

“The rapid growth in deployments of the CyberKnife System around the world is a testament to the promise of robotic radiosurgery for the treatment of a wide variety of tumors,” said Euan S. Thomson, Ph.D., president and CEO of Accuray. “The accuracy and non-invasive nature of CyberKnife radiosurgery gives patients a more convenient and less intrusive option for the treatment of tumors anywhere in the body.”

Currently, HCA has installed CyberKnife Systems in six facilities, including CyberKnife Center of North Florida Radiation Oncology in Gainesville, Fla.; CyberKnife Cancer Center at Memorial Hospital in Jacksonville, Fla.; St. Lucie Medical CyberKnife Treatment Center in Port St. Lucie, Fla.; Central Florida Regional Hospital in Sanford, Fla.; Menorah Medical Center in Overland Park, Kan.; and Methodist CyberKnife Center in San Antonio, Texas.

Filed Under: Healthcare Plan News

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

Posted on December 6, 2008 Written by Annalyn Frame

SAN FRANCISCO, Dec. 6 /PRNewswire/ — Researchers today report that after the implementation of Medicare coverage limitations for erythropoiesis-stimulating agents (ESAs), a significantly greater proportion of anemic cancer patients who were on chemotherapy and who received ESAs needed blood transfusions and utilized more units of blood per patient than those patients who received ESAs prior to implementation of coverage limitations. The findings from this observational study will be presented at the 50th Annual Meeting of the American Society of Hematology on Saturday, December 6th at 9:00 a.m. PST.

In July 2007, the Centers for Medicare and Medicaid Services (CMS) issued coverage limitations, in the form of a National Coverage Determination (NCD), for the use of ESAs in anemic cancer patients receiving chemotherapy. An ongoing, prospective, observational study [Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) registry] is evaluating ESA-treated anemic cancer patients receiving chemotherapy. The present analyses were conducted using data from this study, focused on patients covered by Medicare before and after implementation of the CMS NCD for ESAs.

“We wanted to examine the potential impacts on transfusion patterns and hematologic changes in anemic Medicare patients receiving chemotherapy treated with ESAs before and after implementation of the ESA coverage limitations,” said study director Chris L. Pashos, PhD, Vice President, Abt Bio-Pharma Solutions, Inc. “Our analyses found increased transfusion rates and greater blood utilization in anemic Medicare patients receiving chemotherapy and treated with ESAs after implementation of the ESA NCD compared with before implementation of the ESA NCD.”

Study Methods and Results

Data from 288 Medicare patients (pre-NCD: 230, post-NCD: 58) from 41 sites included in the DOSE registry were analyzed. Data were categorized into two timeframes based on date of initial ESA administration (pre-NCD: April 2006 through April 2007; post-NCD: October 2007 through May 2008). Baseline characteristics of pre-NCD and post-NCD patients were similar for age, gender, weight and tumor type.

Compared to the pre-NCD patient group, a significantly greater proportion of Medicare patients in the post-NCD group received blood transfusions (post-NCD 32.8 percent vs. pre-NCD 18.3 percent, p= 0.0157), with greater blood utilization per patient (mean units of blood/patient: post-NCD 1.1 vs. pre-NCD 0.5, p= 0.0089). Significantly lower mean Hb levels (g/dL) were reported in the post-NCD group at all time points [Hb level (g/dL): post-NCD vs. pre-NCD: 9.6 vs. 10.6, 9.9. vs. 11.1, 10.4 vs. 11.2, 9.8 vs. 11.1 and 9.7 vs. 11.0 at baseline, Week 4, Week 8, Week 12 and Week 16, respectively]. The post-NCD ESA dosing guideline that impacts ESA utilization for anemic cancer patients receiving chemotherapy is the requirement to discontinue ESA dosing for Hb levels exceeding 10 g/dL. Safety, including thrombovascular events, was not examined in this analysis. An increased relative risk of thrombovascular events has been observed in ESA-treated patients; physicians should use the lowest dose needed to avoid red blood cell transfusion.

About the DOSE Registry

The Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry is an ongoing prospective, observational study that aims to characterize ESA dosing patterns, hematologic outcomes, costs and patient-reported outcomes of anemic cancer patients receiving chemotherapy treated in United States (U.S.) oncology clinics. Centocor Ortho Biotech Services, LLC, supported the DOSE registry and this study.

About PROCRIT (Epoetin alfa)

PROCRIT is an ESA used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients who are scheduled for elective noncardiac, nonvascular surgery. Depending on the country in which Epoetin alfa is marketed, these indications may differ.

Important Safety Information

WARNINGS: Increased Mortality, Serious Cardiovascular and Thromboembolic Events, and increased risk of tumor progression OR recurrence

Renal failure: Patients experienced greater risks for death and serious cardiovascular events when administered erythropoiesis-stimulating agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in two clinical studies. Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL.

Cancer:
— ESAs shortened overall survival and/or increased the risk of tumor
progression or recurrence in some clinical studies in patients with
breast, non-small cell lung, head and neck, lymphoid, and cervical
cancers (see WARNINGS: Table 1).
— To decrease these risks, as well as the risk of serious cardio- and
thrombovascular events, use the lowest dose needed to avoid red blood
cell transfusion.
— Use ESAs only for treatment of anemia due to concomitant
myelosuppressive chemotherapy.
— ESAs are not indicated for patients receiving myelosuppressive therapy
when the anticipated outcome is cure.
— Discontinue following the completion of a chemotherapy course.

Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis.

Contraindications
— PROCRIT is contraindicated in patients with uncontrolled hypertension
or with known hypersensitivity to albumin (human) or mammalian
cell-derived products.
Additional Important Safety Information
— Patients with chronic renal failure experienced greater risks for
death and serious cardiovascular events (including myocardial
infarction, stroke, congestive heart failure, and hemodialysis
vascular access thrombosis) when administered ESAs to target higher
versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in
two clinical studies; these risks also increased in controlled
clinical trials of patients with cancer. A rate of hemoglobin rise of
1 g/dL over 2 weeks may contribute to these risks.
— Dose of PROCRIT
— Chronic renal failure patients: The dose of PROCRIT should be
titrated for each patient to achieve and maintain hemoglobin
levels between 10 to 12 g/dL. If a patient does not attain
hemoglobin levels of 10 to 12 g/dL despite 12 weeks of appropriate
PROCRIT therapy, see DOSAGE and ADMINISTRATION in the PROCRIT
Prescribing Information.
— Cancer patients: PROCRIT therapy should not be initiated at
hemoglobin levels greater than or equal to 10 g/dL. The dose of
PROCRIT should be titrated for each patient to achieve and
maintain the lowest hemoglobin level sufficient to avoid the need
for blood transfusion. Discontinue if after 8 weeks of therapy
there is no response as measured by hemoglobin levels or if
transfusions are still required (see recommended Dose Modification
section in DOSAGE and ADMINISTRATION of the PROCRIT Prescribing
Information).
— HIV patients: The dose of PROCRIT should be titrated for each
patient to achieve and maintain the lowest hemoglobin level
sufficient to avoid transfusion and not to exceed the upper safety
limit of 12 g/dL.
— Monitor hemoglobin regularly during therapy, weekly until hemoglobin
becomes stable.
— Cases of pure red cell aplasia (PRCA) and of severe anemia, with or
without other cytopenias, associated with neutralizing antibodies to
erythropoietin have been reported in patients treated with PROCRIT;
predominantly in patients with chronic renal failure receiving PROCRIT
by subcutaneous administration. If any patient develops a sudden loss
of response to PROCRIT, accompanied by severe anemia and low
reticulocyte count, and anti-erythropoietin antibody-associated anemia
is suspected, withhold PROCRIT and other erythropoietic proteins.
Contact ORTHO BIOTECH (1-888-2ASKOBI or 1-888-227-5624) to perform
assays for binding and neutralizing antibodies. If erythropoietin
antibody-mediated anemia is confirmed, PROCRIT should be permanently
discontinued and patients should not be switched to other
erythropoietic proteins.
— The safety and efficacy of PROCRIT therapy have not been established
in patients with a known history of a seizure disorder or underlying
hematologic disease (e.g., sickle cell anemia, myelodysplastic
syndromes, or hypercoagulable disorders).
— In some female patients, menses have resumed following PROCRIT
therapy; the possibility of pregnancy should be discussed and the need
for contraception evaluated.
— Prior to and regularly during PROCRIT therapy monitor iron status;
transferrin saturation should be greater than or equal to 20% and
ferritin should be greater than or equal to 100 ng/mL. During therapy
absolute or functional iron deficiency may develop and all patients
will eventually require supplemental iron to adequately support
erythropoiesis stimulated by PROCRIT.
— Treatment of patients with grossly elevated serum erythropoietin
levels (e.g., >200 mUnits/mL) is not recommended.
— During PROCRIT therapy, blood pressure should be monitored carefully
and aggressively managed, particularly in patients with an underlying
history of hypertension or cardiovascular disease.
— In studies, the most common side effects included fever (pyrexia),
diarrhea, nausea, vomiting, swelling of hands or feet (edema), lack or
loss of strength or weakness (asthenia, fatigue), shortness of breath,
high blood pressure, headache, joint pain (arthralgias), abnormal skin
sensations (as tingling or tickling or itching or burning;
paresthesia), rash, constipation and upper respiratory infection.

Please visit www.procrit.com for the full Prescribing Information, including the Boxed WARNINGS, and for the Medication Guide and Patient Instructions for Use.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients’ health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit www.orthobiotech.com.

Note: Data in this release correspond to ASH abstract 1301

Source: Ortho Biotech Products, L.P.

Filed Under: Healthcare Plan News

Investing in Healthcare Recruiting – Risks and Opportunities

Posted on August 9, 2008 Written by Annalyn Frame

Hospitals and healthcare are definitely on the reliable growth pace. Current industry trend is really reverse to what you would expect, being new to this sector – this is shortage of nurses and medical professionals, meaning that it is rather challenge to find certified applicants, and not really to get new contracts from healthcare organizations. This trends requires the investors to look at healthcare staffing agency from the perspective of its popularity among nurses community – getting nurses opinions on which company is “better” – in the senses of being more friendly, offering better conditions, including faster paychecks issuance. As medical staffing companies actually sells services in the form of recruiting fees, plus W2 services to their medical temps – you should feel the nature of the risks and the opportunities: they are at the management experience, passion and competence side, not in real material assets, such as plants, production tools or even buildings. Let’s try to see the pro and contra arguments:

1. Economy Cycles: Booms and Recessions – healthcare is always in demand, so it should be considered stable and not really exposed to economy cycling. This statement might be considered as a trend, however some companies will suffer from bad economy, but in our opinion mostly due to the recession “atmosphere”.

2. US population “aging” – this is similar to what was long times seen in Europe and Japan, where immigration offset (or even new young immigrants inflow reversed the aging process) was not as active as in United States. Senior population requires more medicine attention and potentially will increase the workload for healthcare staffing organizations, who supply hospitals, nursing homes and retirement communities with nurses and medical doctors.

3. Baby Boomers “contribution”. It is believed to be a factor and it should begin its population aging contribution, in the sense that baby boomers will approach retirement age in five-ten years from now. Maybe it is over estimated, however as new population is growing due to current high rate of immigration into US.

4. Healthcare placement competition is rising. Still, we see large number of privately owned recruiting firms, who are strong on the local and sub-regional markets, so the best way to grow is merges and acquisitions, it is not a good time for new operations launching in the regions. Obviously it is too optimistic to predict that all of these healthcare staffing firms will be absorbed by public healthcare placement providers, however the trends are out there.

5. Sun belt states syndrome. Retiring population has a trend to sell their mortgage paid single family houses in New England, New York, Illinois, California and other mid-west or northern states and move down to Florida, Texas, Georgia, Arizona, and others sun belts states, where they surge new medical nurse inflow.

Andrew Karasev is an independent technical writer for AudioStocks. Crdentia Corp. (CRDT.OB) http://www.crdentia.com 800.803.1777, is one of the nation’s leading providers of healthcare staffing services. Crdentia seeks to capitalize on an opportunity that currently exists in the healthcare industry by targeting the critical Nursing, Physician and Allied Health shortage issue. Crdentia has locations in the following states: Alabama: Birmingham, Arizona: Phoenix and Tucson, North Carolina: Charlotte, Texas: Dallas, Houston, San Antonio, Odessa, Lubbock, Temple, Austin. Author opinion is personal and may not coincide with the company official policy, author agrees with free press rules and article free republishing rights.

Article Source: http://EzineArticles.com/737326

Filed Under: Healthcare Plan News

AMERIGROUP Adds 3 Executives with Healthcare and Government Experience to Team

Posted on June 24, 2008 Written by Annalyn Frame

AMERIGROUP Corporation (NYSE:AGP) has appointed three senior executives to three key senior management positions within AMERIGROUP Corporation.

Steven B. Larsen has been named Senior Vice President for State Government Relations; Tunde Sotunde, M.D., has been named Chief Executive Officer of AMERIGROUP Community Care of Georgia; and Robert A. Wychulis has been named Chief Executive Officer of AMERIGROUP Community Care of New York. [Read more…]

Filed Under: Healthcare Plan News

AARP Announces Next Steps on Medicare Bill

Posted on June 12, 2008 Written by Annalyn Frame

Nancy LeaMond, AARP’s Executive Vice President of Social Impact, has recently announced the Association’s next round of activity to encourage the enactment of the Medicare Improvement for Patients and Providers Act of 2008.

After having been passed by both chambers of Congress with veto-proof margins, the bill now sits with the President. Administration officials have indicated his intention to veto the bill.

“We’re hoping for the best and preparing for everything else,” said LeaMond. “We are not taking any signature or vote for granted. We’ve come too far in this campaign to let up at the end.”

Earlier today, AARP and its volunteers began reaching out to the White House encouraging the President’s signature of the bill. AARP CEO Bill Novelli is sending a letter to the White House asking the President to reconsider his intention to veto given the bill’s strong bipartisan support. The White House also received more than 45,000 emails on Friday from grassroots volunteers encouraging the President to sign the bill today.

AARP is also launching a national effort to thank the overwhelming bipartisan majority of Representatives and Senators who voted to pass the bill and ask them to continue their support in the event of a vote to override a presidential veto.

AARP’s activities early next week will include:

– Coordinated visits from constituents to Washington and district offices of the bill’s supporters;

– A national write-in effort from volunteers to opinion-leaders and news outlets;

– Ads placed in key outlets encouraging a veto override, if necessary; and

– Continued grassroots contacts to legislative offices.

Since launching its national Keep Medicare Fair campaign in April, AARP volunteers have sent more than 910,000 emails, phone calls, faxes and petition signatures to Congress in support of a bill to improve and protect Medicare.

“After months of debate on how to strengthen and protect Medicare, we finally have a bill that would improve low-income, prevention, and mental health programs, and boost health care quality through national e-prescribing,” added LeaMond. “We are confident and hopeful that this bill, which has earned broad bipartisan support, will become law.”

AARP is a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole. AARP does not endorse candidates for public office or make contributions to either political campaigns or candidates. We produce AARP The Magazine, the definitive voice for 50+ Americans and the world’s largest-circulation magazine with over 33 million readers; AARP Bulletin, the go-to news source for AARP’s 39 million members and Americans 50+; AARP Segunda Juventud, the only bilingual U.S. publication dedicated exclusively to the 50+ Hispanic community; and our website, AARP.org. AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. We have staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

Filed Under: AARP

Case Management Society of America CMSA Launches Software Solution for Case Managers

Posted on June 12, 2008 Written by Annalyn Frame

The Case Management Society of America (CMSA) and TCS Healthcare Technologies (TCS) have recently announced a partnership to bring a care management software application, called ACUITY AnyWare, to case managers as a membership benefit of CMSA.

acuity-anywhere

cmsa

This new application, called ACUITY AnyWare, will support individual case managers and small groups through a web-enabled app without having install expensive software or have technical support maintain it.

ACUITY AnyWare allows independents and small groups to transition from paper…to easily run reports. ACUITY AnyWare is the first software that has the Case Management Adherence Guidelines (CMAGs) as an integrated tool.

CMSA members can license ACUITY AnyWare for less than $200 per month.

For more information about ACUITY AnyWare, please contact John Sekerak ([email protected]) at (530) 886-1700 ext. 211 or Robert Pruss ([email protected]) at (501) 673-1142.

Case Management Society of America (www.cmsa.org) is an international non- profit 501(c)(6) multi-disciplinary professional association established in 1990. CMSA is dedicated to the support and advancement of the case management profession through educational forums, networking opportunities, legislative advocacy, and establishing standards to advance the profession. The association is based in Little Rock, AR and serves more than 20,000 members/subscribers and 70 affiliate and pending chapters. Since its inception, CMSA has been at the forefront of setting professional standards for the industry, which allows for the highest level of efficiency and integrity, as well as developing national and local leaders who are recognized for their practice and professional excellence. For more information on CMSA, call CMSA at (501) 225-2229 or go to www.cmsa.org .

TCS Healthcare Technologies (www.tcshealthcare.com) is a leading provider of software and clinical solutions that improve medical management (UM/CM/DM) performance and effectiveness for health plans, insurers, providers, third party administrators, medical management companies, and other health care organizations, who serve both the private and public sectors. For more information about TCS, call (530) 886-1700 ext. 211 or go to www.tcshealthcare.com .

Filed Under: Healthcare Plan News

Susan G. Komen for the Cure’s CEO Hala Moddelmog Earns Recognition at 2008 Trumpet Awards

Posted on January 12, 2008 Written by Annalyn Frame

trumpet-awards

Hala Moddelmog, president and CEO of Susan G. Komen for the Cure, the global leader in the fight to end breast cancer forever, has been recognized for her leadership in business at the 16th annual Trumpet Awards event in Atlanta with a ‘High Heels in High Places’ award.

Hala-Moddelmog

The Trumpet Awards Foundation, Inc. recognizes the contributions and accomplishments of black women and men, including the part they play in ensuring the continued vitality of the nation’s economy. Special recognition is given to ‘the few who symbolize the many who have overcome the ills of racism and poverty to achieve special greatness.’ The Trumpet Awards Foundation, Inc.’s ‘High Heels in High Places’ award salutes women in leadership positions in both the corporate and non-profit worlds. The award made its debut at the 2007 Trumpet Awards gala held in Las Vegas.

susan-g-komen

Moddelmog, a former Fortune 500 executive, became Komen’s CEO in the fall of 2006. In her first year at Komen, she leveraged unique opportunities presented by Komen’s 25th anniversary, its accompanying name change and brand transformation, effectively re-igniting the organization’s promise to save lives and end breast cancer forever while solidifying its position as the global leader in the breast cancer movement.

Prior to coming to Komen, Moddelmog served as founder and CEO of Catalytic Ventures, a consulting firm that worked with private equity investments in the food service industry. She was the first woman in corporate America to lead an international quick service restaurant brand when in 1995 she was named president of Church’s Chicken, a division of Atlanta-based AFC Enterprises. Church’s subsequently realized record sales and profit performance. Moddelmog also held management and marketing positions at Church’s Chicken, Arby’s Franchise Association and BellSouth.

Moddelmog has led Komen in building new alliances with leading cancer organizations in order to reduce duplicated efforts and maximize resources. She has assembled a group of breast cancer thought leaders chaired by distinguished Dana-Farber clinician and Harvard educator, Dr. Eric P. Winer, to form Komen’s new Scientific Advisory Board. Komen has implemented new grants mechanisms to speed the delivery of discoveries and breast cancer cures.

In 2007, Moddelmog saw the organization make the largest grants investment in its 25-year history, more than $77 million. In addition, she encouraged Komen leadership to make public its pledge to invest no less than $2 billion in the coming decade on research and community outreach programs. Moddelmog inaugurated Komen’s global expansion into 10 foreign countries, including several in the Middle East. In the fall of 2007, she led a delegation of breast cancer advocates from the United States to an historic meeting held in Budapest, Hungary with breast cancer advocates from 30 other countries.

Under Moddelmog’s leadership, Komen last year embarked on its 25-city Komen Community Challenge, an educational tour designed to help select U.S. communities close existing gaps in breast cancer and breast health services for the medically uninsured and underserved. The organization published the first-ever State of Breast Cancer report, which has helped people appreciate the advances that have been made in diagnosing and treating breast cancer while understanding the extent of healthcare disparities that keep the latest treatments as well as basic health care out of the reach of millions. In recognition of the tremendous toll breast cancer takes on African Americans in the United States, Circle of Promise, a campaign to engage African Americans with Komen in the fight against breast cancer was launched last fall.

About Susan G. Komen for the Cure
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure(R), we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org/ or call 1-877 GO KOMEN.

Filed Under: Healthcare Plan News

Family Healthcare Network Chooses InteGreat EHR

Posted on April 22, 2007 Written by Annalyn Frame

MED3OOO Group, Inc., a privately held national healthcare management and technology company, recently entered into an agreement to implement and deploy InteGreat EHR, a true browser-based electronic health record (EHR) application, within the Family HealthCare Network (FHCN) community-based clinics throughout Tulare and Kings Counties in California. The installation of InteGreat EHR is designed to improve patient care within the 11 ambulatory clinics with intuitive workflows and clinical decision support, while minimizing bandwidth requirements and improving FHCN’s long-term operations.

Family HealthCare Network serves the healthcare needs of the community within Tulare and Kings Counties of California. Since 1976, they have been dedicated to providing access to care for local farm workers and others who may encounter barriers to healthcare because of financial or transportation issues. The clinic will leverage the InteGreat EHR platform for their 90+ providers to document clinical findings to enhance patient care and improve productivity while securely sharing information from disparate lab and hospital systems.

“Family HealthCare Network spent a considerable amount of time investigating the right EHR choice for our community-based centers,” said Jay S. Kelley, Chief Information Officer of Family HealthCare Network. “We selected the InteGreat EHR because of its ease of use, as well as the expertise the MED3OOO team has in implementing the EHR in community healthcare centers and clinics of all sizes.”

The InteGreat EHR browser-based application costs less for network infrastructure and produces higher levels of satisfaction among clinical staff because it offers a reliable connection without the need for a dedicated line. This technology will save the community health center several thousand dollars in IT costs per year.

“We believe the healthcare management and technology experts at MED3OOO will not only be able to help us successfully implement the InteGreat EHR, but also help us grow our network and proactively manage our patient outcomes,” said Harry Foster, Chief Executive Officer of Family HealthCare Network.

“MED3OOO is excited to have Family HealthCare Network implementing the InteGreat EHR product,” said Patrick Hampson, Chairman and CEO of MED3OOO. “We will be working with the community network with an approach to improve patient and financial outcomes. Our IT operational process and technologies will help the network streamline clinical workflows.”

About MED3OOO

MED3OOO is a national leader in advancing Healthcare Management and Technologies focused on improving performance and adding value to the delivery of healthcare. MED3OOO’s vision is to be considered a “premier operations partner” for physicians, hospitals, employers, and municipalities throughout the U.S. Founded in 1995, MED3OOO provides services to over 15,000 physicians and has become one of the largest and most advanced private management, technology, and information management companies in the United States. InteGreat EHR is a proprietary browser-based technology of MED3OOO used by over 13,000 users to improve clinical and operational outcomes. It adapts to clinical workflows with the highest degree of physician acceptance. InteGreat EHR automates common physician activities, including prescribing, capturing charges, ordering lab tests, viewing results, and documenting clinical encounters. InteGreat EHR uses MEDCIN to document visits, and supports HIPAA compliance programs through comprehensive access audits. For more information, please contact Karla Sartori, MED3OOO Corporate Marketing at 412-937-8887 or [email protected]

MED3OOO logo: http://www.ereleases.com/pr/MED3OOO_logo.jpg

About Family HealthCare Network

Family HealthCare Network (FHCN) is a private, non-profit community-based organization established in 1976 to provide access to care for those in the community who would encounter barriers to healthcare. The organization is governed by a volunteer Board of Directors and has developed a comprehensive primary healthcare delivery system with 11 clinical sites located throughout Tulare and Kings Counties in California’s Central Valley. Family HealthCare Network was the first freestanding ambulatory healthcare center in Tulare County to be accredited by the Joint Commission on Accreditation of Healthcare Organizations. FHCN is licensed by the State of California as a community clinic and is designated as a Federally Qualified Health Center (FQHC). Family HealthCare Network is one of the largest employers in Tulare County with over 700 employees as well as the largest Primary Care Provider. For more information about Family HealthCare Network, visit http://www.FHCN.org.

Filed Under: Healthcare Plan News

FDA Extends Marketing Exclusivity for LEVAQUIN

Posted on March 14, 2007 Written by Annalyn Frame

The U.S. Food and Drug Administration (FDA) has granted LEVAQUIN(R) (levofloxacin) an additional six months of marketing exclusivity, known as “pediatric exclusivity.” The action attaches to the U.S. patent covering LEVAQUIN, extending exclusivity from December 2010 to June 2011. This decision was based on five, company-sponsored pediatric studies conducted at the request of the FDA.

The studies included trials to determine the pharmacokinetic profile and the efficacy and safety of LEVAQUIN in children with community-acquired pneumonia (CAP) and recurrent and/or persistent acute otitis media. The studies were conducted in close collaboration with leaders in the pediatric and infectious disease communities and in consultation with the FDA. LEVAQUIN is not indicated for use in children and adolescents (under 18 years of age).

Since its U.S. introduction in 1996, LEVAQUIN has gained widespread use in the treatment of adults for a variety of bacterial infections caused by specific pathogens(1), including: acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections (mild to moderate), chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections (mild to moderate) and acute pyelonephritis (mild to moderate).

LEVAQUIN is available in 250 mg, 500 mg and 750 mg doses in both oral and I.V. formulations. The safety profile of LEVAQUIN is similar across doses. LEVAQUIN is marketed to healthcare providers by Ortho-McNeil, Inc., and PriCara, Unit of Ortho-McNeil, Inc.

Filed Under: Healthcare Plan News

Study Finds More Obese Teens Undergoing Bariatric Surgery

Posted on March 2, 2007 Written by Annalyn Frame

At a time when there are growing concerns about a national epidemic of obesity among teenagers, a new study focusing on morbidly obese teens who have last-resort bariatric surgery has found that the procedure poses no greater risks for them than for adult patients, and that, in fact, they have a zero death rate and a faster rate of recovery than older patients.

Gastric bypass, stapling or similar procedures known as bariatric surgery is an approach to weight management for morbidly obese patients, which has documented results in improved health outcomes for adults.

Now researchers at the Robert Wood Johnson Medical School and Cincinnati Children’s Hospital Medical Center have used data from a large national database to examine nationwide trends from 1996 to 2003 in the use of adolescent bariatric surgery in the first effort to compare the early postoperative results following bariatric surgery in adolescents and adults.

The study, published in the March issue of Archives of Pediatrics & Adolescent Medicine, shows that surgery among teens has tripled in recent years, increasing in the U.S. from an estimate of just over 200 procedures in 2000 to almost 800 procedures in 2003.

The new study also compared the costs of surgery for adults and teens, finding that adolescents had lower hospital charges. Total hospital charges in 2003 for adolescents undergoing bariatric surgery were $23.6 million and for adults was $3.8 billion. The average hospital charges associated with these procedures were 15 percent lower for adolescents than for adults. Similar to adults, most adolescents had private insurance.

Although bariatric surgery among adolescents has increased, it is by no means a common procedure, representing fewer than one percent of the bariatric procedures performed nationwide. The study found that although the majority of surgery recipients are female, more male adolescents are requesting it.

Filed Under: Healthcare Plan News

Access Pharmaceuticals to Acquire Somanta Pharmaceuticals

Posted on February 21, 2007 Written by Annalyn Frame

Access Pharmaceuticals, Inc. (BULLETIN BOARD: ACCP) and Somanta Pharmaceuticals, Inc. (BULLETIN BOARD: SMPM) have signed a letter of intent for Access to acquire Somanta. Somanta is an Irvine, California based biotechnology company with four novel anti-cancer compounds in development, one of which is currently in Phase 2 clinical trials.

Each of Somanta’s drug candidates acts by a unique mechanism of action, and has the potential to target a wide range of different cancer types. In addition to its significant product pipeline, Somanta brings an experienced team of clinical development and regulatory professionals who have an established track record of guiding compounds through the FDA and EMEA approval processes.

Upon consummation of the acquisition, Somanta’s preferred and common shareholders will receive an aggregate of 1.5 million shares of Access common shares which would represent approximately 13% of the combined company assuming the conversion of Access’ existing convertible debt under existing terms of conversion. The letter of intent is non-binding. The acquisition is expected to close in the second quarter.

“The proposed acquisition of Somanta is very exciting for Access from a number of perspectives,” stated Stephen R. Seiler, Access’ President and CEO. “Somanta comes with four very interesting anti-cancer compounds, one of which is already in Phase 2 clinical trials. Each compound acts by a novel mode of action, and one represents a novel platform technology. As a result, the combined Access and Somanta will have a broad cancer-focused portfolio which will include one approved product, two drug candidates in Phase 2 trials and three novel and exciting pre-clinical products. Our goal has always been to make Access a leader in the oncology space and this acquisition fills out our product pipeline extremely well.”

“In addition, the Somanta clinical development team fits well with our current management group,” continued Mr. Seiler. “I look forward to leveraging their expertise to assist in accelerating and broadening the clinical program for Access’ ProLindac which is in Phase 2 trials in the EU and in the U.S. as well as on our oral insulin program.”

“The proposed combination of Somanta with Access is highly synergistic,” added Agamemnon Epenetos, M.D., Ph.D., Somanta’s CEO. “Each company is at a position where the combination makes strategic sense, and the product pipelines and management teams come together very well, with little overlap. I believe the combined product and technology pipeline is extremely exciting, and I look forward to working closely with the Access team to advance both companies’ products through the development and regulatory process.”

About Somanta
Somanta Pharmaceuticals is a company focused on the development of novel oncology compounds and anti-cancer agents. Somanta’s lead clinical product Sodium Phenylbutyrate (PB) is currently in Phase 2 development. In National Institute of Health sponsored trials, PB has demonstrated the greatest activity in CNS cancers, several of which are “orphan” indications such as Glioblastoma Multiforme. Moreover, promising data has also emerged which suggests PB may be an effective therapy for certain blood cancers and other solid tumors. PB has been well tolerated; its safety profile has generally been established due to its many years of clinical use in pediatrics for inherited urea cycle disorders.

Somanta’s other drug candidates include Alchemix, Prodrax and Angiolix. Alchemix is pan-target inhibitor that is effective in tumor cells resistant to conventional chemotherapy by targeting and irreversibly binding to DNA. Prodrax, a technology platform, is a novel family of prodrugs that enables compounds to remain inert until they reach the hypoxic region of tumors where they become toxic, thus targeting tumor cells which are typically difficult to kill. Somanta believes Alchemix and Prodrax have the ability to overcome many different pathways of drug resistance, and will be studied in a broad range of cancers including lung, colon, ovarian and renal. Proof-of-principle pre- clinical studies have been completed in both of these compounds, and Phase 1 dose escalation trials are being planned. Additionally, Somanta is developing a humanized monoclonal antibody, Angiolix, which appears to induce cell death selectively to tumor blood vessels using a different mode of action than VEGF- oriented therapies. Somanta has prepared clinical development plans for all preclinical projects. For additional information on Somanta Pharmaceuticals, please visit http://www.somanta.com/ .

About Access
Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access’ products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer and MuGard(TM) for the management of patients with mucositis. The Company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com/ .

About ProLindac(TM)
Access’ lead compound, ProLindac(TM), is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. The Company believes that ProLindac’s unique molecular design potentially could eliminate some of the toxic neurological side effects seen in currently marketed DACH platinums. The Company is currently enrolling patients in two Phase II clinical trials, one in ovarian cancer and one in head and neck cancer, and plans to initiate one or more additional Phase II trials, including one in colorectal cancer in 2007.

About MuGard(TM)
Access has received 510(k) clearance from the FDA to market MuGard(TM) in the United States. MuGard(TM) is Access’ proprietary oral rinse product for the management of oral mucositis, the debilitating side-effect which afflicts more than 40% of cancer patients undergoing radiation and chemotherapy. There is currently no well-accepted treatment for mucositis. Access is actively seeking marketing partners in Europe and the US.

About Cobalamin(TM)
The Company is actively pursuing development of its novel Cobalamin(TM) drug delivery technology, particularly as it pertains to the oral delivery of large molecule drugs that are only currently deliverable by injection or subcutaneous administration. Pre-clinical animal studies utilizing Access’ Cobalamin(TM) technology have demonstrated the ability to deliver insulin by oral administration in therapeutic levels.

The conclusion of the acquisition of Somanta by Access as anticipated in the Letter of Intent is subject to a number of conditions, including, without limitation negotiation of a definitive acquisition agreement which will contain standard and customary provisions, completion of due diligence to the full satisfaction of each party, approval by the respective Boards of Directors and by Somanta shareholders, completion of all government filings and receipt of all necessary government approvals and all required third party consents.

Filed Under: Healthcare Plan News

Allied Healthcare International Reports Fiscal 2006 Fourth Quarter and Year-End Results

Posted on December 16, 2006 Written by Annalyn Frame

Allied Healthcare International Inc. (Nasdaq: AHCI; AIM: AHI), a leading provider of flexible healthcare staffing services in the United Kingdom, has announced the financial results of its fiscal 2006 fourth quarter and year-end.

For the fiscal year ended September 30, 2006, the Company generated revenues of $294.6 million, compared with $351.2 million reported in 2005. The $56.6 million decline was mainly due to a reduction in NHS business, which was again driven by a decrease in expenditures and the NHS’s downward price pressure on the cost of agency nurses. Revenues were also impacted by the unfavorable effect of changes in foreign exchange of $8.0 million. Net income for the year, before impairment charges, totaled $7.7 million, or $0.17 per diluted share, compared with net income, before charges, of $20.2 million, or $0.45 per diluted share for the comparable period last year. With the addition of impairment charges, which reduced 2006 results by $131.4 million, or $2.92 per diluted share, the Company reported a net loss of $123.8 million, or $2.75 per diluted share, compared with earnings after charges in 2005 of $18.7 million, or $0.41 per diluted share.

The Company’s 2006 fourth quarter and year-end results were negatively impacted by a total of $131.4 million of impairment charges, net of taxes, resulting from charges for goodwill and long-lived assets of $120.1 million and $11.3 million, respectively, which were determined after the company completed its annual impairment testing in the fourth quarter. The long-lived asset impairment charge represents $4.3 million for cylinders, redundant plant and software related to the transfer of the Company’s historical oxygen distribution business, $6.3 million associated with the decision to discontinue the implementation of the Oracle front-office operating system, and $0.7 million related to impairment of other intangibles.

Gross profit margins for the year, as adjusted, remained strong and increased to 30.4%, compared with 29.5% reported in 2005. The increase in gross margin resulted from the Company’s continued emphasis on its higher-margin, Social Services business, and a decreased emphasis on its lower-margin, NHS business. The Company’s reported gross profit mix for the year, as adjusted, is as follows: 65% Social Services, 16% Nursing homes, 14% NHS, and 5% Oxygen.

For the fourth quarter ended September 30, 2006, the Company generated revenue of $74.5 million, compared with $84.3 million reported for the comparable quarter last year. Net income for the quarter, before impairment charges, reached $0.3 million, or $0.01 per diluted share, compared with net income before charges of $5.7 million, or $0.13 per diluted share for the comparable period in 2005. Net loss in the fourth quarter, after impairment charges, was $131.1 million, or $2.92 per diluted share, compared with net income after charges of $4.2 million, or $0.09 per diluted share for the fourth quarter of 2005.

Gross profit margins for the fourth quarter, as adjusted, remained strong at 29.8%, absorbing the full impact of the lower respiratory margins, compared to 30.9% reported for the comparable quarter last year. The strong gross margin resulted from the Company’s continued emphasis on its higher-margin, Social Services business, and a decreased emphasis on its lower-margin, NHS business. The Company’s reported gross profit mix for the fourth quarter, as adjusted, is as follows: 69% Social Services, 15% Nursing Homes, 11% NHS, and 5% Oxygen.

The Company reported selling, general and administration (SG&A) costs for the year of $75.6 million, compared with $74.0 million last year. The increase was a result of significant investments in its Allied Respiratory division where patient numbers more than doubled from that which was originally anticipated, and the Company is now servicing over 12,500 individuals. As a result, the Company had a disproportionate increase in SG&A expenses of $3.6 million, and anticipates costs relative to the oxygen business to significantly decrease going forward. Additional costs were also related to increased levels of IT depreciation and maintenance costs of $2.7 million, and stock based compensation costs of $0.7 million. These costs were partially offset by savings in the Company’s flexible staffing division of $3.6 million, and the effects of foreign exchange.

The Company reported selling, general and administration (SG&A) costs for the fourth quarter of $20.7 million, compared with $20.4 million last year. Similarly, the increase was a result of costs associated with the investment in the respiratory business, and an increased level of IT depreciation and maintenance costs associated with the implementation of the Oracle accounting and payroll systems.

The Company will maintain its emphasis on growing the Social Services business and is poised to continue to deliver services at home.

“The positive results in our core social services business were obscured by the contraction in the nursing market and the investment in the Oxygen business,” said Timothy Aitken, Chairman and Chief Executive Officer. “Despite these challenges, the Company successfully transitioned the flexible staffing business to homecare services and the emerging complex care market, which is the foundation for our future growth.”

Mr. Aitken concluded: “During 2006, management focused on improving the operating structure of the Company, rationalizing the branch network and reducing costs relative to the NHS business. In 2007, the Company is poised to leverage our branch network to deliver Community Care in partnership with Local Government and achieve improved operating results.”

Allied Healthcare invites all those interested in hearing management’s discussion of the results to join the call by dialing 877-407-9205 for domestic participants and 201-689-8054 for international participants at 10:00 AM EST on Thursday, December 14, 2006. A replay will be available for one week following the call by dialing 877-660-6853 for domestic participants and 201-612-7415 for international participants, and entering account number 286 and conference ID number 223788 when prompted. Participants may also access a live Webcast of the conference call through the “Investors” section of Allied Healthcare’s Website, www.alliedhealthcare.com. The presentation will be available and archived for 90 days.

In addition to disclosing results of operations that are determined in accordance with generally accepted accounting principles (”GAAP”), this press release also discloses non-GAAP results of operations that exclude or include certain charges. These non-GAAP measures adjust for charges that are unusual. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding the Company’s results of operations, as these non-GAAP measures allow investors to better evaluate ongoing business performance. Management also uses these non-GAAP measures internally to assess the performance of its business and to establish operational goals. Investors should consider non-GAAP measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP.

About Allied Healthcare International
Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately 100 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of Private Patients, Community Care, Nursing Homes and Hospitals. The Company also supplies medical-grade oxygen in the form of cylinders and concentrators to patients in the U.K.

Filed Under: Healthcare Plan News

AHC Healthcare Receivables Management Partners with Tucson Medical Center

Posted on November 20, 2006 Written by Annalyn Frame

Nationally recognized healthcare reimbursement experts, Tracy Knowles, Esq., Senior Vice President for AHC, and Maria Persons, Corporate Director of Patient Financial Services for Tucson Medical Center, recently provided education to the Texas Chapter of American Association of Health Care Administrative Management.

Their seminar, Managing Usual and Customary Denials, discussed the manner in which healthcare providers can develop a payer specific approach to resolve reimbursement reduction issues. The educational conference was attended by over 60 individuals from hospitals and health systems, specialized healthcare providers, and sponsoring organizations.

Representative provider organizations in attendance included:
Arlington Memorial Hospital
Baylor Health Care System
Children’s Medical Center
East Texas Medical Center
Harris Methodist Southlake
HCA Healthcare
Hill Country Memorial Hospital
Hopkins County Memorial Hospital
Hunt Memorial Hospital District
Methodist Health System
Parkland Health & Hospital System
Texas Health Resources
Triumph Healthcare
University Medical Center
UT Southwestern Medical Center at Dallas
Wilson N. Jones

Workshop attendees received education on the various tactics employed by payers, state statutes, federal regulations, case law, correct guidelines utilized in determining “reasonableness” of charges for each payer type, and appropriateness of patient involvement in each payer situation.

Having completed over 160 seminars this year, AHC maintains their commitment to the healthcare community by providing complimentary, on-site healthcare reimbursement education. Interested parties who wish to schedule a complimentary workshop for their hospital business office staff may contact AHC at (888) 511-7901 or visit www.ahcinc.com.

About AHC
AHC Healthcare Receivables Management (www.ahcinc.com) provides technology enabled accounts receivables management solutions and complimentary education offerings for the healthcare community. Employing over 500 healthcare reimbursement professionals, approximately 100 of which are attorneys, AHC utilizes federal and state regulations, established case law, and client specific protocols to provide guaranteed results to our 760 clients nationwide. AHC has offices in Virginia, New York, Florida, Illinois, and California.

Filed Under: Healthcare Plan News

American Community Introduces Affordable Health Insurance Options

Posted on October 30, 2006 Written by Annalyn Frame

American Community Mutual Insurance Company has introduced two new consumer-choice health insurance plans for employer groups, families and individuals in Illinois, Iowa, Missouri and Nebraska. The new plans are designed to make health insurance more affordable, especially for small employer groups that may not be able to afford traditional coverage, the self-employed, and those not in employee-sponsored group plans, such as young adults who may no longer be eligible under a parent’s coverage.

The Next Generation HSA and Triple Tier PPO are low-cost PPO (preferred provider) health plans that take a creative approach to risk- and cost-sharing to reduce premiums, while assuring financial protection against catastrophic hospital and medical costs. The plans were introduced earlier this year in Michigan, Indiana and Ohio. Both plans include an industry-leading assortment of self-directed care management tools to help insureds stay healthy, make more informed use of health services, and receive access to health experts 24-hours a day.

The Next Generation HSA is a qualified high-deductible health insurance plan with unique features. These types of plans typically allow the insured to pay deductibles and co-payments from a tax-free Health Savings Account, but American Community adds three innovations, according to Gerald Meach, President and CEO.

First, it offers multiple payment-sharing options to help people select coverage to best fit their needs. Second, the family plan offers the option of a separate, lower deductible for individuals, letting them begin benefits earlier. Third, the deductible is waived for the first 30 days of care after an accident. “This best-in-class benefit saves members from being hit hard with unexpected expenses,” said Meach.

The Triple Tier PPO plan offers lower premiums by providing different benefit levels based on type of care. “The plan provides higher benefits for hospitalizations, emergency care and injuries, the most serious and costly treatments, with lesser benefits for outpatient, non-emergency care where the policyholder can take the time to evaluate, with our assistance, alternatives that can be more cost effective,” he explained.

Both the Next Generation HSA and Triple Tier PPO allow choice of doctors and healthcare providers, with highest benefits for insureds who use preferred providers recognized by American Community.

The company’s new plans offer a TelaDoc physician phone line, 24-hour nurse line, treatment cost calculator, web-based medical library, personal health & symptom evaluation tool, prescription drug pricing and research info, hospital cost comparisons, and health helper tips.

American Community is licensed in 38 states and has embarked on an aggressive program of geographic growth and coverage innovations to help keep health care affordable, according to Meach. The company plans to launch two new consumer-choice products in early 2007.

With beginnings dating back to 1938, American Community is one of the nation’s oldest health insurance companies. Today it markets coverage in Michigan, Ohio, Indiana, Illinois, Missouri, Iowa, Nebraska and Arizona through more than 6,000 independent insurance agents.

For more information about these new products, visit www.american-community.com.

Filed Under: Healthcare Plan News

Acupressure Technique is Credited with Relieving Prostate Cancer Symptoms

Posted on October 18, 2006 Written by Annalyn Frame

In May 2004, Jonas Slonaker participated in a nine-day, on-camera retreat to focus on using Emotional Freedom Techniques (EFT) to address his symptoms of prostate cancer. He continues to do EFT daily; and today he is still free of any cancer symptoms, and his last three PSA (prostate-specific antigen) counts were “barely over two.”

EFT involves fingertip tapping on select acupressure points while focusing on the physical symptom or unresolved emotion in question. EFT claims an 80% success rate in calming symptoms associated with serious diseases like cancer. It can be learned without cost by downloading the free EFT Manual here.

“What is remarkable about using EFT for serious diseases,” says EFT Founder Gary Craig, “is that when we persistently address unresolved emotional issues and traumas, the symptoms associated with the disease tend to fade … often permanently. In Jonas’s case, he was harboring a deep and unresolved anger at his abusive father. In about 40 minutes of doing EFT together, he no longer felt the explosive anger towards his father.”

Jonas reports, “I urinate just fine and have no pain down there. I stopped taking the medication that helped me urinate. My story is simple. I use EFT everyday to release emotional energy blocks in my system. If I don’t have a particular issue or emotion to release, then I tap and sing the word Love over and over. I tap every morning for fifteen minutes to get my day started. Then I tap whenever the need arises. If someone snaps at me at work, I tap and let that go before it can become a repetitive resentment. Many of the times when I tap, I go into a deep state of peace and now and again I experience radiant joy. EFT helped me reach a place of great love and acceptance and I honestly don’t believe the cancer can survive in that environment.”

To witness Jonas’s on-camera EFT session, the combined set of DVD’s, which contains 40 hours of instruction and demonstrations, costs only $72 at https://www.emofree.com/Store/store.aspx.

More than a decade of reports from thousands of EFT users has convinced Craig of the connection between people’s unresolved emotions and their physical issues. Now an increasing number of medical studies are making the same connections, but EFT claims to offer a simple solution to resolving the emotional component of disease.

Craig says, “We are not advocating that people adopt EFT instead of conventional medicine to treat serious diseases. But medical research is consistently showing that unresolved emotional traumas, anger, and resentment contribute to disease. EFT provides a drug-free way for people to permanently clear the unresolved emotions that are disrupting their energy systems, taxing their immune systems and causing disease.”

Belgian physician Dr. Tania de Winne uses EFT in her medical practice and sees consistent evidence of the mind-body connection with her patients. “While I have no proof that EFT prevents cancer,” she says, “I’m convinced that it does just that. Negative thoughts are a major cause of not just cancer but all illnesses, and since EFT quickly eliminates the energy blocks that contribute to negative thoughts and emotions, I believe cancer and most other diseases can ultimately be eradicated by using EFT on a daily basis.”

According to the National Institutes of Health, about 1500 people in the U.S. die of cancer each day and another 3400 are diagnosed with cancer daily. “In my view,” says Craig, “people are dying needlessly from unresolved emotions like anger, fear, guilt and resentment.”

Physician, Dr. Eric Robins adds, “Some day the medical profession will wake up and realize that unresolved emotional issues are the main cause of 85% of all illnesses. When they do, EFT will be one of their primary healing tools …. as it is for me.”

EFT is still a new procedure, but already over 350,000 — including thousands of health care practitioners have downloaded Craig’s free training manual and another 10,000 download it each month. EFT often works when nothing else will, even on serious diseases like cancer. Word of mouth is making EFT a top self-healing modality. The EFT website is the fifth most actively visited natural health site in the world.

The EFT Manual gives anyone all the basics so they can apply it right away. It can be freely downloaded here.

Filed Under: Healthcare Plan News

Age-Related Macular Degeneration Can Lead to Depression and Suicide

Posted on September 21, 2006 Written by Annalyn Frame

A White Paper issued today by AMD Alliance International (AMDAI) reports that the impact of vision loss due to age-related macular degeneration (AMD) on patients’ Quality of Life and psychological well-being is comparable to that of cancer or coronary heart disease. The White Paper also shows the diagnosis of AMD and the threat of blindness increases depression and the risk of suicide.

America’s leading vision, seniors and research organizations have joined forces, under the umbrella of AMD Alliance International, to call on health policy makers, healthcare professionals and the AMD community to take immediate action to combat the risks of depression, suicide and social isolation linked to age related macular degeneration, the leading cause of vision loss in the USA. According to AMD Alliance International, the dire consequences of AMD can be prevented by early detection, measures taken during diagnosis, and providing access to low vision rehabilitation and support services. More than 15 million American seniors live with some form of AMD, and this number is expected to reach potentially epidemic proportions as the population ages.

“AMD is no longer just about vision loss. It’s also about mental health and quality of life, which is why identifying and catching AMD at its earliest stages is critical. People, especially those over 50, must have regular eye examinations,” said Don Curran, Chairman, AMD Alliance International and AMD patient. “Further, health policy makers need to acknowledge that quality of life is an important patient outcome and recognize the urgent need to provide timely access to physicians, treatments, and support services to limit the damage caused by AMD. The pieces for optimal AMD care exist, but the puzzle must be put together. A good life with AMD is very possible, with the right supports at the right time.” According to Dr. Tara Cortes, RN, PhD President and CEO, Lighthouse International, “Early detection and treatment are essential, especially for those with wet macular degeneration. In addition, in many cases, low vision rehabilitation and counseling is the right support. We must accelerate our efforts to make low vision rehabilitation available to all those who need it.”

The White Paper, issued to kick off the 2006 AMD Awareness Week, September 18 to 24, 2006, also marks the start of a global outreach campaign to raise awareness of the little-known psychological effects of AMD. The campaign aims to demonstrate that basic supports to improve AMD patients’ quality of life – early access to medical expertise, early diagnosis and treatment, and referral to appropriate low vision programs, including counseling – are vital. As AMD is the leading cause of vision loss in the Western World in people 50 and older, and with cases rising as the baby boomer generation ages, more people are at risk of suffering from more than just vision loss.

People with vision loss are more than three times as likely to suffer from depression versus the general population. At its worst, depression can lead to suicide, a tragic fatality associated with the loss of about 850,000 lives worldwide every year, according to the World Health Organization (WHO).

Further studies included in the White Paper analysis show quality of life for an AMD patient to be an underestimated outcome at both the clinical and public levels. Other studies show that the inclusion of low-vision care services help to reduce the negative impact of the AMD diagnosis, empower patients and help them adjust to living with the disease.

In addition to an increased risk of depression, the White Paper notes how AMD adversely affects day to day life. People with AMD are eight times more likely to have difficulties shopping, 12 times more likely to have problems using a telephone and nine times more likely to experience difficulties doing simple house work. The condition also puts patients at higher risk of accidents such as hip fractures, and many with the disease are unable to drive. All of these factors together lead to depression and sense of isolation that many people with AMD needlessly experience.

“Education, awareness, and good clinical care are important in reducing the impact of AMD on the quality of life. At the same time, investments in research are leading to more effective therapies to limit the effects of the disease,” says Stephen Rose, Ph.D., Chief Research Officer, Foundation Fighting Blindness (FFB). “Our goal is to fund research that will put an end to all retinal degenerative diseases including AMD. FFB-funded researchers are making excellent progress in identifying the genetic and lifestyle factors that lead to AMD, and they are moving promising preventions, treatments, and cures into clinical trials and the marketplace.”

About AMD
AMD is a degenerative disease that affects the central part of the retina – the area responsible for central vision, which allows us to read, drive and recognize faces. As central vision breaks down, only peripheral vision remains. There are two types of AMD: wet and dry. Dry AMD is the most common form of the disease, accounting for about 80 per cent of all cases. Dry AMD occurs when light-sensitive cells in the macula slowly break down. Approximately 10 to 20 per cent of cases will progress to wet AMD. Wet AMD occurs when abnormal blood vessels are formed under and leak into the macula. Blood vessel growth in wet AMD progresses much more rapidly than the dry form and accounts for the majority of cases in which severe vision loss occur.

AMD causes more than 14 million cases of visual impairment worldwide each year. More than 15 million American seniors live with some form of AMD, and this number is expected to reach potentially epidemic proportions as the population ages. AMD is even more prevalent among people who smoke. Evidence shows that smoking doubles the risk of developing AMD, while some studies suggest the risk could be as high as three- to four-fold. The World Health Organization recognizes smoking as the only modifiable risk factor for AMD. For more detailed information about AMD, consult http://www.amdalliance.org.

About AMD Alliance International
The AMD Alliance International is a global non-profit coalition of vision, seniors’ and research organisations working to raise awareness of age-related macular degeneration (AMD), the leading cause of vision loss in older populations. The AMD Alliance International promote regular eye examinations and provide education about prevention, treatments, rehabilitation, and support services available for AMD. Comprising 55 organisations in 22 countries, the AMD Alliance International is the only international organisation focused exclusively on AMD.

The mission of the Alliance is “to bring knowledge, help and hope to individuals and families around the world affected by AMD through:
– Generating awareness and understanding of AMD;
– Promoting the importance of education, early detection, knowledge of
treatment and rehabilitation options; and
– Preserving vision and improving the quality of life of individuals
affected by AMD.”

The American members of AMD Alliance International who join forces in this awareness effort are (in alphabetical order) The Alliance for Aging Research, The Deicke Centre for Visual Rehabilitation, The Foundation Fighting Blindness, Lighthouse International, Macular Degeneration Partnership, Macular Degeneration Support, Prevent Blindness America, and The Seniors Coalition.

Filed Under: Healthcare Plan News

New Rogaine Foam Features VersaFoam

Posted on September 5, 2006 Written by Annalyn Frame

Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announces the use of its proprietary VersaFoam(R) technology in Pfizer Consumer Healthcare’s new Men’s Rogaine(R) Foam, now available wherever Rogaine is sold. In January 2006, Pfizer received FDA approval for Men’s Rogaine(R) Foam (minoxidil, 5%) developed under a license from Connetics’ VersaFoam technology.

“Rogaine is the most popular topical treatment for hair loss. A Rogaine formulation utilizing Connetics’ VersaFoam technology offers patients suffering from hair loss a convenient therapy that absorbs rapidly upon contact with the scalp leaving minimal residue,” said Thomas G. Wiggans, Chief Executive Officer of Connetics. “Connetics’ innovative skin delivery vehicles have created strong customer acceptance and leading brands in the prescription topical steroid and antibiotic markets. We believe the elegance of our VersaFoam delivery system also holds potential to increase patient compliance and to expand the current market for Rogaine.”

“We are very happy to be partnering with Connetics, a leader in foam technology, to provide this novel formulation for the hair loss patient,” says Dr. Bruce Kohut, Senior Director of Dermatology at Pfizer Consumer Healthcare. “We expect that patients will find the new Rogaine Foam easy to use and an enjoyable experience.”

About VersaFoam Technology
As a leader in novel topical delivery systems, Connetics owns worldwide rights to a number of unique topical delivery systems and has branded its proprietary foam drug delivery vehicle, VersaFoam. This unique, versatile topical drug delivery vehicle quickly absorbs into the skin when applied and has versatility for application on multiple body sites. The formulation is thermolabile, which melts at skin temperature and evaporates quickly. In addition, it is easy to apply, non-dripping, stain-free and leaves minimal to no residue. It is also preservative-free. The VersaFoam system has important cosmetic and functional benefits compared with conventional delivery vehicles including creams, ointments, gels and lotions. Connetics’ VersaFoam-based products are OLUX(R) for scalp dermatoses and non-scalp psoriasis, Luxiq(R) Foam for scalp dermatoses and Evoclin(R) Foam for the treatment of acne. These formulations have earned wide acceptance by physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance. For more information on VersaFoam, please visit www.VersaFoam.com.

About Connetics
Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market. Connetics’ innovative approach to product development includes the exploration of new ways to optimize drug delivery at targeted treatment sites on the skin, and the assessment of novel formulation and delivery technologies. The Company’s marketed products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin (clindamycin) Foam, 1%. Connetics is developing Desilux(TM) (desonide) Foam, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) (clobetasol propionate) Foam, 0.05%, a super high-potency topical steroid formulation to treat atopic dermatitis and plaque psoriasis; Extina(R) (ketoconazole) Foam, 2%, to treat seborrheic dermatitis; and Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, to treat acne. Connetics’ product formulations are designed to improve the management of dermatological diseases and provide significant product differentiation. For more information about Connetics and its products, please visit www.connetics.com.

Filed Under: Healthcare Plan News

Acupressure Technique Relieves Huntington’s Disease Symptoms

Posted on July 17, 2006 Written by Annalyn Frame

While researchers have spent ten years developing a cure for Huntington’s Disease (HD) in mice, people suffering with the disease have gained symptom relief with a simple do-it-yourself acupressure technique. According to the theory behind Emotional Freedom Techniques (EFT), illness and disease are caused by unresolved emotional issues and a disrupted energy meridian system (Chi or Qi). When emotional issues are resolved using EFT, physical symptoms associated with serious diseases have been shown to clear, sometimes immediately and often permanently.

EFT is a do-it-yourself acupressure technique that anybody can use to provide relief from the physical and emotional symptoms associated with HD. It involves fingertip tapping on select acupressure points while focusing on the symptom in question. EFT claims an 80% success rate in calming symptoms associated with serious diseases.

It and can be learned freely by downloading the EFT Manual at http://www.emofree.com/downloadeftmanual.asp?ref=prwHDcw

Researchers from the University of British Columbia have found a way to block the enzyme believed to be instrumental in the development of the disease. For the next five years, researchers will focus on developing and testing a drug that will achieve the same results in humans.

In the meantime, EFT is giving HD patients drug-free relief from the symptoms associated with this degenerative brain disease. EFT theory takes a very different approach to addressing symptoms associated with such diseases.

According to Gary Craig, the Stanford-trained engineer who developed EFT, “When EFT Practitioners approach serious diseases such as Huntington’s, we look at the person’s symptoms and the emotions associated with their symptoms. When we address illness-related emotions like fear, frustration, and grief, we repeatedly find that the symptoms subside, even disappear.”

Children of HD patients have a 50% chance of inheriting Huntington’s. If they have inherited the disease, symptoms generally appear later in life. “I can’t help but wonder whether applying EFT could postpone or even suspend the development of symptoms,” says Craig.

Diane Kendrick is an EFT Practitioner in the United Kingdom whose client had Huntington’s disease. The client presented as having a phobia about walking down stairs, but her HD was evidenced in her slurred speech, jerky gait, twitching and labored breathing.

Because of her symptoms, the woman had difficulty tapping the EFT points, so had her husband do it for her. When she returned a week later, Diane was surprised, “I couldn’t believe the changes in her. Her visual symptoms were about 60% improved.” Her jerkiness and twitching had subsided and her communication had improved. Her speech was less slurred and more clear. During the week between appointments, the woman had done EFT tapping every day on her own. It had become increasingly easy to do as her coordination and enthusiasm had improved.

They did a little more EFT for the phobia of stairs and the woman pinpointed having fallen down stairs ten years previously. With five minutes of EFT, she went up and down stairs with no trace of fear or anxiety. The phobia was gone, but more importantly, she had a considerable improvement in several of the symptoms associated with her incurable physical condition.

Craig explains, “We see this repeatedly with EFT, where addressing a specific issue like a phobia has a generalized positive result for the person’s health. We are not claiming that EFT cures diseases, but EFT users all over the world have experienced remarkable results in the reduction of symptoms associated with cancer, diabetes, Parkinson’s disease, Crohn’s disease, lupus, Alzheimer’s disease, MS, arthritis and others. Fortunately, an increasing number of health professionals are incorporating EFT into their medical practices.”

There are no known side effects associated with EFT and it often gives symptom relief where nothing else works. “It is my goal,” says Craig, “to encourage the use of EFT to compliment any medical protocol employed to treat serious diseases. To this end, I make the EFT Manual available freely on the EFT website.”

Although most Americans have yet to hear of it, EFT may be the world’s fastest-growing self-help technique. Over 300,000 have downloaded Craig’s free training manual and another 10,000 download it each month. The official EFT Manual has been translated by volunteer practitioners into nine languages.

The EFT Manual explains the basics so that anyone can begin applying EFT right away. It can be freely downloaded at
http://www.emofree.com/downloadeftmanual.asp?ref=prwHDcw

For further information, contact Gary Craig at 707-785-2848.

Filed Under: Healthcare Plan News

ADVANTAGE Health Solutions Announces Multi-Year Contract With Athens Medical Group

Posted on April 26, 2006 Written by Annalyn Frame

Athens Medical Group and ADVANTAGE Health Solutions, Inc.(SM), a regional managed care health plan owned by the Sisters of St. Francis and Ascension Health, have signed a multi-year contract to provide health care in the Montgomery County region. This addition to ADVANTAGE’s local network of providers, which includes St. Clare Medical Center, was announced today by Brett Spencer, MD, CEO of Athens and Vicki Perry, president and CEO of ADVANTAGE.

This agreement will allow those enrolled in ADVANTAGE’s Point of Service and HMO plans to select a physician from the Athens Medical Group for their primary care physician. In addition, this new agreement allows ADVANTAGE to kick off its marketing campaign in Crawfordsville, Ind., to health insurance brokers and employers. Employers such as IVY Tech, Eli Lilly, St. Clare, DaimlerChrysler and Subaru already offer the ADVANTAGE plan to their employees. More than 200 employer groups in Indiana offer ADVANTAGE.

With the addition of Athens Medical Group, ADVANTAGE now has more than 5,010 health care providers participating in managed care commercial products. This includes nearly 1,229 primary care providers, over 3,755 specialists, and 26 acute care hospitals throughout Indiana.

Athens Medical Group and ADVANTAGE pursue high standards of medical care and work diligently to improve the health of the communities they serve. “Thanks to our relationship with Athens Medical Group, we can bring our principles of outstanding service, individualized attention, and quality focus to Montgomery County,” said Perry. “Our goal is to enhance the health and well-being of our members, and we look forward to achieving that goal with our new network of providers.”

ADVANTAGE’s growing network in the Crawfordsville, Lafayette and Indianapolis areas serve employers large and small with a variety of benefit plan options, including preventive care, medical services, prescription drugs, vision and dental benefits. ADVANTAGE also offers health savings accounts, which allow employees more flexibility in their health care spending.

ADVANTAGE plans encourage members to practice prevention and healthy lifestyle habits. More than 25 percent of Indiana residents are overweight or obese. Reactionary health care is no longer enough to maintain public health. ADVANTAGE works with providers like Athens Medical Group to increase the number of members using preventative health care and to decrease the need for reactionary health care.

About ADVANTAGE Health Solutions, Inc.(SM)
ADVANTAGE is a managed care organization offering HMO, POS, and self funded benefit plans, as well as a high deductible plan with an HSA option and a Medicare Advantage product. Founded by four Catholic health care systems — Ascension Health, Sisters of St. Francis Health Services, Inc., Saint Joseph Regional Medical Center, Inc., and Ancilla Health Systems, Inc., ADVANTAGE began its operations in 2000 as a spin-off from Sagamore Health Network. Since inception, ADVANTAGE has achieved significant milestones, such as its NCQA Excellent Accreditation status, and is one of the fastest growing managed care organizations in Indiana, serving more than 65,000 members. For more information on ADVANTAGE or their ADVANTAGE Preferred Plus plans go to www.advantageplan.com.

Filed Under: Healthcare Plan News

AMA Insurance Agency to Offer CIGNATURE Rx(SM) Medicare Drug Plan to Retired Physicians

Posted on April 5, 2006 Written by Annalyn Frame

CIGNA HealthCare* today announced an agreement with AMA Insurance Agency, Inc. (AMAIAI) to market the CIGNATURE Rx(SM) Medicare prescription drug plans to Medicare-eligible physicians and their spouses. “We are delighted AMAIAI has chosen to offer CIGNA’s Medicare prescription drug plans,” said Terri Swanson, vice president of CIGNA Senior Care. “This decision represents a strong new relationship based on a high level of trust in our Part D program.”

AMA Insurance Agency, Inc., a wholly owned subsidiary of the American Medical Association, markets and/or administers insurance plans and related products to meet the needs of physicians and their families. AMAIAI chose the simple, affordable CIGNATURE Rx drug coverage because of several leading features:

comprehensive coverage and choice of plans, which align well with the prescription drug needs of physicians and their spouses; broad availability in all regions of the country and in more than 53,000 pharmacies nationwide; and high quality customer service, ensuring all calls are answered by experienced service representatives. For more details about CIGNATURE Rx for Medicare-eligible physicians, contact CIGNA at 1.800.374.3406.

About CIGNA
CIGNA is offering its Medicare Part D plans in all 50 states and the District of Columbia in alliance with NationsHealth, Inc. (NASDAQ:NHRX)(NASDAQ:NHRXU)(NASDAQ:NHRXW). The alliance combines CIGNA’s pharmacy product capabilities with NationsHealth’s experience in service and distribution to the Medicare population.

*CIGNA HealthCare, headquartered in Bloomfield, CT, provides pharmacy benefits and products and services that integrate and analyze information to support consumerism and health advocacy. “CIGNA” and “CIGNA HealthCare” refer to various operating subsidiaries of CIGNA Corporation (NYSE:CI) including Connecticut General Life Insurance Company. Products and services are provided by these operating subsidiaries and not by CIGNA Corporation.

About AMAIAI
Established in 1988 as a wholly owned subsidiary of the American Medical Association, AMA Insurance Agency, Inc. markets and/or administers a variety of insurance plans and related products to meet the needs of physicians, resident physicians, medical students, and their families. Select products are available for physicians’ group practices.

Filed Under: Healthcare Plan News

AHC Healthcare Receivables Management Offers Hospitals a Full Spectrum of Reimbursement Services through Acquisition of Comprehensive Healthcare Solutions

Posted on April 3, 2006 Written by Annalyn Frame

AHC Healthcare Receivables Management, an industry leader in providing third-party reimbursement solutions and complimentary education offerings, announced today the completion of the company’s acquisition of Comprehensive Healthcare Solutions (CHS), a division of CB Accounts, Inc. CHS, with offices in Peoria and Jacksonville, Illinois and Baltimore, Maryland is a national healthcare accounts receivable management firm offering early-out self-pay programs, self-pay after insurance services, and Out-of-State Medicaid billing and follow-up.

This acquisition enables AHC to offer comprehensive “patient centric” reimbursement programs to healthcare providers. “Patient centric” reimbursement programs enable AHC, on behalf of its hospital clients, to address both third-party payer and patient follow-up requirements, including eligibility and enrollment services, ensuring maximum reimbursement for healthcare providers while offering a single, blended pricing structure. This integrated service approach will simplify invoices for healthcare providers, remove the challenges associated with managing multiple vendors, and improve patient satisfaction by reducing the number of parties a patient needs to interact with during the payment/recovery process. Most importantly, the hospital can be assured it is recovering the appropriate monies from the appropriate responsible party(ies).

“This acquisition provides us greater expertise in the patient recovery process, which, combined with our historic expertise and reputation recovering monies from insurance companies, gives us unlimited potential to meet the future needs of healthcare providers, ” states AHC President, David Langsam. “Expanding our product lines will allow us to deliver a more comprehensive service offering to our clients and the healthcare marketplace in general.”

For more information about AHC’s “Patient Centric” Reimbursement Programs or to schedule a complimentary, state specific, in-service workshop on “Insurance Reimbursement Law”, contact AHC toll free at (888) 511-7901.

About AHC:
AHC Healthcare Receivables Management (www.ahcinc.com) specializes in accounts receivable management solutions for the healthcare industry. Employing over 500 healthcare professionals, approximately 100 of which are attorneys, AHC utilizes federal and state regulations, established case law, and client specific protocols to provide guaranteed accounts receivable management solutions to our 750 clients nationwide. AHC operates out of eight locations, with headquarters located in Manassas, Virginia.

Filed Under: Healthcare Plan News

Top 10 Types of Health Insurance Plans in America

Posted on March 22, 2006 Written by Annalyn Frame

There are more and more forms of health insurance are showing in our society, since competition of health insurance is increase. Now I am list and briefly describe 10 of the most popular types of health inusrance plans in the United State below:

INDIVIDUAL INSURANCE: Ensuring a person individually is a common mode of insurance. This is a process through which one may be selective about what s/he wants in a plan. Accordingly, one’s required premium is calculated, and the insurance plan takes effect.

GROUP INSURANCE: Through this type of insurance, one is compelled to abide by what others are going for, and this is also dependent on the insurance providers. They are the ones that decide what is feasible to include in a plan, and on that basis a group insurance can take place.
PPO:This is the Preferred Provider Organization. If a person has membership of this organization, they can be treated by doctors within the setup. This is because of the arrangement they have; it is such that when a member gets ill, they are treated by their own panel. Otherwise, one has to pay for treatment outside the network.

HMO: The Health Maintenance Organization is one that allows a member to select a particular doctor off the panel. It is these selected doctors that will deal will with members’ problems. The selected doctor is the one that will be approached for checkups of any kind, and if there are problems with a member that cannot be handled by him or her, the member is referred to specialists.

MSA: This is a Medical Savings Account that is also tax-advantaged. It is used for health insurance policy that has high premiums to be paid. Members have to save money in this account in order to pay for their medical bills, which include checkups, treatments, etc. The fact that tax does not apply to it, makes it a good strategy towards coping with high premiums in health insurance.

POS: This is a Point-of-Service Plan, which implements properties of the HMO and PPO plans. Through this arrangement, a member of this plan can either go to any doctor in the network or go to one outside the network. However, generally this is the concept that allows flexibility.
INDEMNITY PLAN:This plan allows one to go to any doctor when one needs to; there are no restrictions on this, and it is believed to be more of a traditional plan. One does not need permission to go to a particular health care provider. However, usually what happens is that the member pays 20% of the total fee for treatment while the insurance provider pays 80%. In addition to this, there is a period through which one pays up in this manner, and then the company takes over paying the whole 100%.

THE PROVIDER: This insurance is like the services provided through the Medicare program.

PCP: This is Primary Care Physician, and it refers to the first provider that a member is associated with. This provider is responsible for making sure that all basic checks are made, and if there are further areas to check up on, the member has to be referred to a specialist.
GENERAL COVERAGE WITH HEALTH & LIFE PROTECTION:This form of insurance includes life coverage as well as health coverage.

Filed Under: Healthcare Plan News

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20

Search Our Site

Ketamine Therapy Dallas
Ketamine Treatment Clinic Dallas

Categories

  • AARP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Copyright © 2023 - Privacy Policy - Terms of Use - Disclaimer